Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,35912,278,1.74 [0.88-3.42],0.1112348304485827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,34908,268,1.09 [0.87-1.36],0.4441976843589265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,41045,321,1.25 [1.05-1.48],0.0125111029048873
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,34731,268,0.89 [0.64-1.25],0.5085242176636389
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,40801,319,1.00 [0.84-1.19],0.980105726814055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,41045,321,1.02 [0.88-1.18],0.7771790261973861
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,35885,280,1.00 [0.92-1.08],0.926335315352065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,34731,268,1.04 [0.87-1.24],0.6475421905118222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",40301,312,1.01 [0.90-1.15],0.8221895740745937
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",35197,269,0.91 [0.75-1.09],0.2945887516573531
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",35859,278,0.95 [0.83-1.08],0.4070256061870529
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,40835,319,1.08 [0.76-1.55],0.6632247366892742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,35885,280,0.81 [0.53-1.23],0.3133481508424489
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,40502,311,1.02 [0.84-1.24],0.845521689290073
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,35096,275,0.70 [0.48-1.00],0.0503481439611399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,35707,278,1.04 [0.94-1.15],0.4728092727131057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,41239,323,0.94 [0.77-1.15],0.5274812039605223
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,34825,269,0.94 [0.72-1.22],0.6309049821394632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,41425,324,0.90 [0.67-1.22],0.5131554537333998
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,41549,321,1.02 [0.88-1.18],0.7927431713564566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,35697,278,1.04 [0.78-1.39],0.7777027696250798
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,34825,269,0.86 [0.74-1.01],0.0616540989172081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,34731,268,0.88 [0.63-1.25],0.4835037099078627
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",40502,311,1.49 [1.24-1.77],1.285763146778758e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,34731,268,1.09 [0.90-1.32],0.3897341860884248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,40496,312,1.23 [0.94-1.60],0.1390094978521729
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,40867,318,2.48 [1.72-3.59],1.2208854945724028e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,41239,323,1.04 [0.88-1.22],0.6705111966880581
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,34731,268,1.02 [0.82-1.26],0.864047225917309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,34963,273,1.17 [0.99-1.40],0.0722161500842098
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,41710,326,1.48 [1.16-1.90],0.0018273344057125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,40997,319,1.92 [1.55-2.37],1.96880229336709e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,34825,269,1.67 [1.30-2.15],5.847055397607759e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40502,311,1.96 [1.42-2.70],4.722553358371559e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40937,319,1.24 [0.94-1.65],0.1268307216495622
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,41710,326,1.13 [0.85-1.51],0.3914742990111555
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,41531,322,3.68 [2.89-4.69],7.289267134232985e-26
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,35707,278,1.88 [1.33-2.66],0.0003836619412347
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,34825,269,0.96 [0.66-1.40],0.8303716655425498
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,41742,327,0.62 [0.41-0.93],0.0215774535278931
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,41045,321,1.09 [0.86-1.38],0.4673479672933899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40502,311,1.19 [0.92-1.55],0.1927272637730853
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,34825,269,1.13 [0.82-1.56],0.4605502840952368
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,41351,323,0.75 [0.60-0.93],0.0076955479893166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,35864,278,1.04 [0.74-1.48],0.806464314647759
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,34908,268,1.53 [0.94-2.50],0.0855638630174078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,35859,278,0.71 [0.53-0.95],0.0215178226979028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,40301,312,0.87 [0.62-1.21],0.4063123867679673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,35096,275,0.88 [0.75-1.04],0.1277125887926695
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,40867,318,1.02 [0.76-1.38],0.8823529593862357
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,35096,275,0.65 [0.47-0.88],0.0060708939126353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,35707,278,2.04 [1.70-2.45],9.346634993332276e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,41402,323,2.13 [1.53-2.97],7.786796574982453e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,41544,326,2.08 [1.61-2.69],2.0734844970756254e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,35859,278,1.54 [1.02-2.31],0.038502135796395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,41045,321,1.08 [0.96-1.22],0.2144888096503632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,41239,323,1.24 [0.86-1.79],0.2449482388440236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,34760,267,0.97 [0.81-1.15],0.7076369192703438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,35096,275,0.90 [0.77-1.05],0.1844429189729516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40502,311,1.10 [0.97-1.24],0.1330170881519027
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,35912,278,1.13 [0.96-1.34],0.1448436714953767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,41611,321,1.41 [0.96-2.07],0.0823419848859552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,34731,268,0.97 [0.82-1.15],0.7280243145529425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,35096,275,1.00 [0.87-1.15],0.9936499690561612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFM,Afamin,35912,278,0.50 [0.28-0.89],0.0182916797425344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,40805,316,1.17 [1.01-1.36],0.0320764459866704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,34760,267,0.95 [0.84-1.08],0.4153885353938308
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,41128,321,1.06 [0.83-1.35],0.6606979598337552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,39949,314,1.14 [1.04-1.26],0.0081022206172923
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,40235,312,0.93 [0.78-1.11],0.413503608036494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,41402,323,1.36 [1.03-1.81],0.0312755917389959
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,41710,326,1.03 [0.85-1.24],0.7746431254808884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,35885,280,0.69 [0.48-0.98],0.0357555438079716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,41239,323,1.06 [0.94-1.21],0.353910034944816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,41239,323,1.05 [0.91-1.21],0.5124981499837731
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,34908,268,1.57 [1.12-2.19],0.0084015462139839
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,34908,268,1.08 [0.73-1.59],0.7138611096918416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,35697,278,1.03 [0.87-1.21],0.752523249795128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,35885,280,1.33 [0.87-2.02],0.182276074553207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,41174,323,1.02 [0.91-1.15],0.7171404762487048
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",34892,262,1.05 [0.92-1.20],0.4570014536855686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,40301,312,1.16 [0.96-1.40],0.1229188308458106
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,34908,268,0.87 [0.69-1.10],0.2554628163610782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40977,321,1.04 [0.95-1.14],0.3847833421698183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,41239,323,1.02 [0.88-1.19],0.7575021301924683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",35790,277,1.01 [0.91-1.13],0.8352736401568563
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,35096,275,1.41 [0.88-2.27],0.1560081068339223
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,40301,312,1.08 [0.95-1.24],0.2305358639103185
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,34892,262,1.00 [0.82-1.21],0.9913549110918104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,40502,311,1.18 [1.00-1.39],0.0492439915809702
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,34825,269,1.02 [0.86-1.20],0.8533047721336672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,40279,316,1.10 [0.95-1.28],0.2090647329202762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,35805,276,1.01 [0.93-1.11],0.7531330463872778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,40106,311,0.97 [0.81-1.16],0.7573555916827375
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,41742,327,2.37 [1.45-3.87],0.0005962663429188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,41247,323,0.99 [0.82-1.19],0.9004762986938508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",35697,278,1.07 [0.87-1.32],0.5039411645147723
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",41131,324,1.09 [0.95-1.25],0.2290756173218686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",35805,276,1.15 [0.91-1.45],0.2465240997554734
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,35197,269,1.10 [0.87-1.41],0.4264731541655653
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,34825,269,0.95 [0.86-1.04],0.2487731367434824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",41045,321,1.07 [0.97-1.17],0.1842775553862248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,40496,312,0.87 [0.59-1.29],0.4963902648264643
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,41552,321,1.48 [0.91-2.43],0.1158111519720252
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,35864,278,1.17 [0.75-1.83],0.4832012888900612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,40279,316,1.14 [0.99-1.32],0.0756146256975459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,34892,262,1.03 [0.82-1.30],0.80009581960473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,41045,321,1.54 [1.01-2.36],0.0471297040236079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,40496,312,1.16 [0.94-1.43],0.159259016620789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,35096,275,0.89 [0.66-1.20],0.4488814983520457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,35573,278,1.20 [0.98-1.48],0.0815033523230923
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,35790,277,1.13 [0.97-1.32],0.1286825870046558
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,33593,270,1.20 [0.97-1.48],0.1002934891813925
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,39663,311,1.07 [0.87-1.32],0.529085881598627
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,38444,298,1.11 [0.90-1.37],0.3320751520450012
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,41129,320,1.14 [0.85-1.53],0.3692889464880055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,41080,319,1.01 [0.90-1.14],0.8716871805950258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,41611,321,1.58 [1.23-2.02],0.0002972040207774
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,40652,318,1.12 [0.79-1.57],0.5313404808062326
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,41266,322,1.17 [0.92-1.50],0.2074196456563388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,41257,321,1.04 [0.79-1.38],0.7675389537842952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,41341,322,1.20 [0.96-1.50],0.1026823339971084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,41611,321,0.94 [0.71-1.23],0.6424103098351812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,34731,268,0.90 [0.75-1.07],0.2368430587955577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,34825,269,0.98 [0.84-1.13],0.7757854450646142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,34602,264,0.98 [0.79-1.21],0.8546789825852801
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,40301,312,1.05 [0.89-1.24],0.5572707394861225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,34908,268,1.19 [0.93-1.51],0.1717872428637161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,41323,322,0.79 [0.55-1.14],0.2161246769512161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,34891,274,1.09 [0.84-1.40],0.5213999200536783
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,40279,316,1.08 [0.96-1.21],0.1929058812009269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,41128,324,0.96 [0.83-1.11],0.5920232910151733
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,34392,266,1.25 [1.08-1.45],0.0023446780794907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,41531,322,0.99 [0.86-1.14],0.8762137240978144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,41044,323,0.99 [0.86-1.13],0.8629463977609619
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,40156,316,1.15 [0.83-1.59],0.4075848512888388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],40496,312,0.88 [0.72-1.07],0.2018664588464652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,41390,323,0.83 [0.60-1.15],0.2717855356446503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,35697,278,1.02 [0.88-1.18],0.7990654196721408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,34892,262,1.28 [1.03-1.60],0.0294746816855605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,35707,278,1.02 [0.88-1.18],0.816289876880044
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,35790,277,1.21 [0.96-1.53],0.1013503155681779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,41045,321,1.45 [1.22-1.73],2.697873182344292e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,35584,275,1.20 [0.85-1.70],0.2908832438845771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,41487,321,1.23 [1.05-1.44],0.0103607935209873
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,41239,323,0.85 [0.70-1.03],0.089588313545298
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,35912,278,0.56 [0.35-0.89],0.0147748642343648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,35885,280,1.12 [0.89-1.42],0.3262849678541353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,35912,278,0.93 [0.66-1.30],0.6658014779671831
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,35885,280,0.94 [0.57-1.54],0.8062609216517491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,34908,268,0.63 [0.49-0.82],0.0005154239392693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,35840,275,0.59 [0.43-0.82],0.0018119186369868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,34272,257,0.74 [0.52-1.04],0.0821538532138495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,35912,278,1.07 [0.92-1.24],0.3728889800198002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,35885,280,0.95 [0.61-1.47],0.8204565300736679
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,41247,323,0.76 [0.57-1.00],0.0486977108936317
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,35885,280,0.99 [0.82-1.21],0.9457172070998212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,41330,322,0.48 [0.34-0.68],2.596004303059275e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,41188,322,1.06 [0.91-1.23],0.4485186702561174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,35096,275,0.95 [0.86-1.05],0.3279929986853332
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,40877,319,1.13 [0.91-1.40],0.2557726832229532
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,35197,269,1.13 [0.96-1.32],0.134817894489257
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,41045,321,1.38 [1.12-1.71],0.0027177477191397
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,35707,278,0.96 [0.86-1.07],0.4284550485784288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,35805,276,0.95 [0.80-1.12],0.5512814248905387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,41039,319,1.17 [0.97-1.41],0.1046605240305584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",35697,278,1.09 [0.85-1.41],0.483310441288926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,40301,312,1.12 [0.90-1.39],0.3147273502957335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,40301,312,1.18 [1.00-1.37],0.0436460383416915
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,35197,269,1.21 [0.94-1.55],0.1475082950448367
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,35096,275,1.01 [0.87-1.16],0.9102425326536776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,34602,264,0.92 [0.78-1.08],0.3211712705612269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,35790,277,1.06 [0.93-1.21],0.3708029229319242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,35805,276,1.04 [0.92-1.17],0.5489020272062533
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,41195,324,1.01 [0.92-1.11],0.8656179179515548
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,34760,267,1.10 [0.95-1.28],0.2112601781464264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,34760,267,1.12 [0.84-1.48],0.4490136952655731
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,40279,316,1.18 [0.96-1.45],0.117029681102788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,34731,268,1.02 [0.86-1.20],0.8406044435418484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,34731,268,1.09 [0.82-1.45],0.5551574362625447
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,34760,267,0.99 [0.82-1.21],0.9568002782978792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,40496,312,1.27 [1.01-1.62],0.0442456973880642
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,34731,268,0.89 [0.70-1.14],0.3631334334267863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,41247,323,1.07 [0.86-1.33],0.5626688454378035
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,41045,321,1.23 [1.04-1.47],0.0175218541689898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,41390,323,1.10 [0.83-1.47],0.4937577631164974
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,34760,267,0.88 [0.71-1.09],0.2362650316934463
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,40496,312,1.19 [0.99-1.43],0.0613626702790054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,35537,275,1.14 [0.90-1.44],0.2806779259385439
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,40937,319,1.09 [0.90-1.32],0.3759212558782863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,40937,319,1.64 [1.19-2.25],0.002273260028681
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,35885,280,1.85 [1.22-2.80],0.0035861874040171
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,35859,278,0.59 [0.38-0.92],0.0201942960273196
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,35805,276,1.03 [0.87-1.22],0.7492124354369216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,34908,268,1.02 [0.91-1.15],0.6948630617744572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,34731,268,0.93 [0.80-1.09],0.3718410860606007
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,40279,316,0.99 [0.85-1.15],0.9033717340407288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,34602,264,0.88 [0.61-1.26],0.4824130090406062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,35707,278,1.03 [0.90-1.18],0.6181758837950504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,40301,312,1.09 [0.92-1.29],0.3027580890491639
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,41351,323,1.11 [0.97-1.28],0.1329272796612737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,34731,268,1.04 [0.82-1.31],0.7652269608682625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,34731,268,1.28 [0.92-1.78],0.1496529260838651
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,34731,268,0.88 [0.64-1.21],0.4204083152248921
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,34602,264,1.04 [0.79-1.37],0.7855427181682193
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,34731,268,1.10 [0.93-1.30],0.2638140411280464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",34731,268,1.07 [0.87-1.32],0.515462098937429
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",41402,323,0.96 [0.88-1.05],0.3876558413396036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",40279,316,0.96 [0.75-1.22],0.7376306788952041
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,40301,312,1.15 [0.92-1.44],0.210607246744091
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,41045,321,1.10 [0.76-1.59],0.5982570456910514
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,40203,316,0.97 [0.83-1.13],0.7070720592806836
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,34908,268,1.04 [0.88-1.22],0.6662168065029727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,34731,268,1.05 [0.94-1.19],0.3703493272948065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,35707,278,1.53 [1.22-1.91],0.0002618555378555
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",35912,278,0.50 [0.25-0.98],0.0441919764956816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,40279,316,1.09 [0.95-1.25],0.2424455817538022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,34760,267,0.98 [0.87-1.09],0.659219783296183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,35805,276,1.12 [0.89-1.41],0.3262489961355371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,35790,277,1.08 [0.90-1.29],0.4202039168146899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,41195,324,1.01 [0.91-1.12],0.8262574431775809
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,41390,323,1.45 [1.02-2.06],0.0401784177853413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,35805,276,1.06 [0.86-1.30],0.6008106495059242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,39970,309,1.09 [0.96-1.23],0.1755549559117282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,35912,278,1.65 [1.43-1.90],3.364109900496279e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,34731,268,0.75 [0.41-1.36],0.3427413559755116
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",34908,268,0.95 [0.69-1.30],0.7297647727404939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",41402,323,2.34 [1.66-3.29],1.1956848415732202e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",41247,323,0.81 [0.54-1.21],0.3041775809363842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,34825,269,1.18 [0.81-1.70],0.3944707785270229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,41195,324,1.08 [0.95-1.24],0.2427624143293694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,40867,318,1.10 [0.85-1.41],0.4721028340262625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,34825,269,1.19 [0.95-1.49],0.1207234915717489
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,40502,311,1.35 [1.03-1.77],0.0317602950457549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,40301,312,1.23 [1.06-1.43],0.00644283767965
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,40301,312,1.94 [1.45-2.61],9.568042267277329e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,41195,324,1.03 [0.94-1.14],0.4746435785694962
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,35790,277,1.30 [1.15-1.48],3.406071019756378e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,34892,262,1.09 [0.97-1.23],0.1518189492919163
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,40219,316,1.09 [0.98-1.22],0.1262311214986994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,41247,323,1.28 [0.85-1.92],0.237394210240564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,40937,319,0.98 [0.73-1.30],0.8674986590360179
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",35859,278,1.30 [0.92-1.85],0.1397090647599855
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",34760,267,1.07 [0.87-1.31],0.5072161723252051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,35214,276,0.77 [0.52-1.14],0.1884379553570696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,35707,278,1.88 [1.70-2.08],3.423768876966372e-35
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,35790,277,0.98 [0.87-1.10],0.7427483879642445
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",41195,324,1.16 [0.91-1.47],0.2220263531435463
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,34825,269,1.21 [1.01-1.44],0.0347257368462658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,34602,264,1.17 [1.00-1.37],0.0534027921748912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,35697,278,0.95 [0.74-1.23],0.7062674328473537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,41195,324,1.06 [0.95-1.18],0.2771404841978336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,35864,278,1.04 [0.91-1.19],0.5885500309757303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,34908,268,1.14 [0.94-1.38],0.171115117965885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,34602,264,1.01 [0.78-1.30],0.9432351936887154
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,35864,278,0.93 [0.82-1.06],0.2824500308715727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,40236,312,1.08 [1.00-1.18],0.0615433519008557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,34760,267,0.86 [0.72-1.03],0.1030105726682261
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,34731,268,0.84 [0.53-1.32],0.448853570565726
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,41195,324,0.95 [0.82-1.10],0.4842485820438581
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,41247,323,1.00 [0.90-1.11],0.981811685824994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,40301,312,1.08 [0.92-1.26],0.3380287866181304
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,41742,327,1.16 [0.85-1.57],0.3536405359312223
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,34825,269,1.85 [1.53-2.25],4.0241516589180504e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,34760,267,1.16 [1.01-1.32],0.0383817175616781
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,35790,277,1.01 [0.76-1.34],0.9403776721558716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,41247,323,1.06 [0.92-1.22],0.4432838001887705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,35096,275,0.78 [0.52-1.17],0.2256852487439585
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,40867,318,0.82 [0.65-1.03],0.0834345469999612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,40436,311,1.11 [0.87-1.43],0.3926193304561344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,35096,275,1.39 [0.85-2.29],0.1901864466730673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,35859,278,1.04 [0.75-1.46],0.8054896406638785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,34825,269,1.41 [1.11-1.79],0.0050717273320878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,40502,311,1.19 [0.77-1.84],0.427475640056449
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,34760,267,1.09 [0.89-1.35],0.3926497002737054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,34908,268,1.23 [0.99-1.52],0.0634446090700439
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,33680,260,1.01 [0.90-1.12],0.9064488863785776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,41155,324,1.08 [0.93-1.26],0.3234121544839134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,35797,278,1.00 [0.84-1.18],0.9643420251052708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,35375,278,1.01 [0.91-1.13],0.7991131166069003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,35197,269,1.14 [0.79-1.64],0.4833418028264824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,34760,267,0.81 [0.56-1.18],0.2745739212089472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,34731,268,1.08 [0.87-1.35],0.475150719462038
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,34731,268,1.01 [0.74-1.40],0.92810494028062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,40279,316,1.39 [1.12-1.73],0.0024142850055932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,34760,267,0.85 [0.62-1.16],0.3080211721575266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,35805,276,0.91 [0.67-1.24],0.5513155691667501
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BSG,Basigin,41636,325,1.83 [1.12-3.00],0.01619432723436
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BSND,Barttin,34602,264,1.03 [0.73-1.46],0.8503671038960545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,41603,324,1.43 [1.10-1.86],0.0084405203144922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,41603,324,1.20 [1.01-1.43],0.0431465330364228
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,40301,312,0.97 [0.85-1.11],0.6823672210275518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,35912,278,0.77 [0.45-1.32],0.3418358579514459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,34602,264,1.01 [0.88-1.15],0.903826166589473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,35628,277,1.00 [0.75-1.34],0.9858800580144093
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,41402,323,2.86 [2.05-3.97],4.4275407539740926e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,41195,324,1.89 [1.53-2.33],4.325324859603469e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,34602,264,1.00 [0.74-1.33],0.9776633510488832
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,40279,316,1.19 [1.04-1.36],0.0134738434244392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,34731,268,0.99 [0.69-1.44],0.977618461904948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,41501,325,3.60 [2.46-5.28],5.180721143052213e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",35805,276,0.99 [0.84-1.16],0.8626058817633009
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,34825,269,1.31 [1.03-1.67],0.0304738478403277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,41390,323,0.92 [0.73-1.16],0.4739436774105493
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,35096,275,0.86 [0.63-1.17],0.3466692611464292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,35805,276,1.23 [0.89-1.70],0.2026733134329411
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,35030,275,0.89 [0.70-1.12],0.307785413961917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,35912,278,1.02 [0.55-1.89],0.9447093757001668
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,35845,278,4.29 [2.36-7.80],1.7752012657753695e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,35912,278,1.83 [1.08-3.10],0.0256626821876448
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2,Complement C2,41330,322,0.67 [0.50-0.89],0.0055558447097663
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,40203,316,1.19 [0.96-1.47],0.1048269147671222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,34892,262,1.09 [0.90-1.31],0.3751408036197793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C3,Complement C3,34086,264,0.78 [0.58-1.05],0.0952084938645718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,41351,323,1.17 [0.92-1.50],0.1988366994605749
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C5,Complement C5,35912,278,0.99 [0.46-2.13],0.9860708266012852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,35051,271,1.99 [1.38-2.88],0.0002420472105899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,35790,277,1.34 [0.91-1.97],0.1421584384022066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,35912,278,0.92 [0.63-1.34],0.668319228961133
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,35885,280,1.54 [1.23-1.92],0.0001380734758579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,35707,278,1.06 [0.92-1.22],0.4145596547788315
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,40342,317,1.02 [0.86-1.20],0.8306938147870236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,40301,312,1.14 [0.85-1.52],0.3742549816787768
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,41045,321,1.37 [1.02-1.85],0.034271844125141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,40777,321,0.96 [0.87-1.05],0.3441209541911644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,41611,321,0.88 [0.66-1.16],0.362710622941824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,41112,322,1.07 [0.93-1.23],0.3177981403107945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,41678,327,1.09 [0.93-1.28],0.2670180003123572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,41742,327,1.03 [0.68-1.55],0.890692575292359
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",40502,311,1.14 [1.03-1.27],0.0146985422724776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,41117,323,0.87 [0.74-1.02],0.0799406223533604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,35197,269,1.06 [0.76-1.46],0.7322778517756401
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,34825,269,1.00 [0.64-1.56],0.9911280150846742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,41611,321,1.07 [0.87-1.32],0.5363228024845148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,34892,262,1.02 [0.85-1.22],0.826347993362794
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,34760,267,0.83 [0.57-1.23],0.3555138448968639
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,34731,268,0.82 [0.64-1.05],0.1144732958486275
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,34760,267,1.06 [0.88-1.28],0.5411600231874576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,35805,276,0.98 [0.86-1.13],0.8244196367260398
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,35025,274,1.02 [0.91-1.14],0.7587030007010145
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,34892,262,1.09 [0.84-1.43],0.5208924693066879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,41045,321,1.04 [0.83-1.31],0.7359656827238801
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,40279,316,1.18 [0.87-1.60],0.2895274376336675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,40861,319,1.16 [1.00-1.35],0.0561891725911788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,35790,277,1.00 [0.74-1.33],0.9744684512261692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,41484,321,1.00 [0.91-1.10],0.9829018917634336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,34908,268,1.15 [0.99-1.34],0.0651318645877974
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,34731,268,0.95 [0.69-1.31],0.7561954077051535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,40301,312,1.38 [1.12-1.70],0.0022177347397914
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,34892,262,0.90 [0.71-1.13],0.3659887683941771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,35805,276,0.99 [0.89-1.11],0.9110620138983696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,41108,321,4.49 [2.78-7.24],8.229449722534853e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,40970,319,1.23 [1.04-1.44],0.0133922845093385
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,35697,278,1.01 [0.74-1.36],0.9653509256418376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,35790,277,0.96 [0.85-1.09],0.5149728728817731
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,40279,316,1.00 [0.83-1.21],0.9873840762116038
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,34892,262,1.31 [1.00-1.71],0.0473825422685962
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,40279,316,1.10 [0.96-1.26],0.1581107525053769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,40279,316,1.04 [0.90-1.19],0.601549565016896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,41195,324,1.00 [0.87-1.16],0.9738603243931938
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,41742,327,1.01 [0.90-1.13],0.878539436858089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,35197,269,0.96 [0.89-1.03],0.2553558907806103
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,35790,277,1.07 [0.94-1.23],0.314121245784169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,41490,321,1.06 [0.91-1.24],0.4581793316265747
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,34825,269,1.04 [0.86-1.25],0.6819652993418557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,34731,268,0.77 [0.58-1.04],0.0858175215910554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAT,Catalase,35348,277,0.98 [0.79-1.21],0.8310255288360392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,41184,322,1.06 [0.93-1.21],0.3686217705745409
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,34760,267,0.98 [0.86-1.11],0.7244242011686663
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,41611,321,0.89 [0.66-1.21],0.4666003445468413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,34908,268,1.11 [0.89-1.38],0.3522807646545258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,34731,268,1.28 [1.01-1.61],0.0396000080375546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40937,319,1.07 [0.94-1.22],0.3265066970466455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,35790,277,1.09 [0.91-1.32],0.3448573080237587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,35697,278,1.09 [0.87-1.37],0.4665743091681147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,34892,262,0.71 [0.47-1.06],0.094688859331428
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,35805,276,1.15 [1.01-1.30],0.0402519036612024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,41239,323,1.20 [0.91-1.57],0.1952002841094644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,34908,268,1.04 [0.86-1.25],0.6991359518686406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,41710,326,1.30 [1.00-1.68],0.0492354331921978
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,41643,326,1.05 [0.91-1.21],0.4735573536689801
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,41129,320,1.59 [1.30-1.95],9.655507669914042e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,41742,327,1.45 [1.18-1.79],0.0003775762940838
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,41742,327,1.15 [0.95-1.39],0.1616637527866012
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,41147,321,1.18 [1.06-1.31],0.0025970400488738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,40664,318,1.21 [1.07-1.36],0.0024045742060212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,41603,324,1.10 [1.03-1.17],0.0065710415047731
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,40867,318,1.12 [0.93-1.34],0.2378394632572472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,41710,326,1.06 [0.96-1.18],0.2459317187751821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,41402,323,1.58 [1.33-1.87],1.3435238288197977e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,40797,321,1.40 [1.17-1.67],0.0002137597383406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,41402,323,1.23 [0.97-1.56],0.0816044811565105
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,41341,322,1.24 [1.10-1.39],0.0002836669342651
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,41710,326,1.06 [0.87-1.30],0.542354197036387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,41195,324,1.11 [1.01-1.22],0.0312052478983473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,41239,323,1.01 [0.86-1.19],0.8767321818228623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,41057,324,1.12 [0.95-1.32],0.169425841702255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,41195,324,1.37 [1.24-1.50],7.339280428079032e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,41275,322,1.23 [1.10-1.37],0.0003500079243576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,41390,323,0.95 [0.86-1.05],0.3127304447023519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,41195,324,1.19 [1.02-1.38],0.0235978710765534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,41552,321,1.30 [1.10-1.53],0.0019082203033338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,40979,321,0.93 [0.82-1.06],0.2741727132481005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,41213,320,0.94 [0.79-1.12],0.5043403186729701
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,41672,327,1.32 [0.99-1.75],0.0569822625292909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,41611,321,1.33 [1.06-1.69],0.0158989716140443
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,41247,323,1.13 [0.88-1.46],0.3378518515445811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,35197,269,1.00 [0.73-1.38],0.9879783058066698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,34825,269,1.13 [1.02-1.25],0.0239714440842071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,40937,319,1.02 [0.83-1.25],0.8617413896388637
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,40301,312,1.07 [0.86-1.33],0.5353024627481195
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,35707,278,0.82 [0.64-1.06],0.1301603550025117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,41247,323,0.97 [0.72-1.31],0.8468484244842113
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,40399,318,1.53 [1.21-1.92],0.000299526241963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,41710,326,1.67 [1.37-2.03],2.979556156056064e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,41390,323,1.41 [1.13-1.76],0.0023381679109246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,41247,323,1.06 [0.74-1.52],0.7617634378035114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,34892,262,1.04 [0.76-1.44],0.8013484306449086
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,41185,322,1.09 [1.00-1.18],0.038210389107895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,41351,323,2.56 [1.69-3.88],9.044672196611302e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,34731,268,1.40 [1.14-1.71],0.0015026191287984
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,41195,324,2.19 [1.57-3.07],4.847691553149172e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,41061,324,1.58 [1.21-2.07],0.0007832504619179
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,40307,314,0.82 [0.63-1.07],0.1432068993080069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,41333,322,0.83 [0.64-1.07],0.1512072274287398
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,41710,326,3.24 [2.77-3.80],1.1547017001384836e-48
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,34825,269,1.03 [0.78-1.36],0.8571051657209174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,41710,326,1.63 [1.15-2.31],0.0062368193723972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,35864,278,0.87 [0.66-1.16],0.3574319740167944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,41351,323,3.71 [3.08-4.46],5.324283500789391e-44
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,40937,319,2.25 [1.80-2.81],1.1840518988411029e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,41202,322,1.28 [0.96-1.69],0.0877497337200782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,40301,312,2.41 [2.12-2.72],2.782318874343826e-43
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,41239,323,0.98 [0.84-1.14],0.7857117025018265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,35096,275,2.10 [1.46-3.04],7.304880848630709e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,41603,324,1.68 [1.28-2.21],0.0001892743731854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,41476,319,2.09 [1.68-2.60],3.3845720382031236e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,41611,321,1.64 [1.36-1.98],2.409285233692677e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,41247,323,0.95 [0.73-1.24],0.6970799586726197
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,41045,321,1.87 [1.38-2.53],4.457217342578427e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,41351,323,1.03 [0.91-1.17],0.6204534905192968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,41461,324,1.01 [0.67-1.52],0.9513534725087424
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,34825,269,0.99 [0.76-1.28],0.9391448114395712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,41045,321,1.57 [1.16-2.14],0.0038069883603933
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,34760,267,1.24 [0.92-1.67],0.1643957141357971
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,35197,269,1.29 [1.02-1.63],0.0353249467290672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,34825,269,1.04 [0.92-1.17],0.5699021366964256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,41121,324,1.74 [1.41-2.15],2.4361621890842764e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,41214,321,1.23 [1.02-1.49],0.0323758807911187
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,41710,326,0.99 [0.87-1.12],0.8416583787964185
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,40993,319,1.64 [1.19-2.26],0.0023144709900943
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,41341,322,3.63 [2.66-4.94],3.372728458873297e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,41552,321,3.46 [2.88-4.16],3.3568947293693166e-40
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,39801,311,1.08 [0.74-1.59],0.6812855914600379
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,41134,322,1.35 [0.77-2.37],0.289909419782792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,39751,307,1.65 [1.10-2.50],0.0163918467970219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,35723,274,2.07 [1.65-2.61],5.619609934232142e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,41636,325,1.50 [1.25-1.81],1.6877604283842035e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,40867,318,1.00 [0.82-1.21],0.9827134381938372
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,41048,321,0.99 [0.89-1.11],0.919045214929173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,34759,269,2.03 [1.68-2.45],2.5973516158929015e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,41195,324,3.38 [2.84-4.03],1.5023976747677262e-42
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,35096,275,4.77 [3.96-5.75],1.8976583541115287e-60
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,41603,324,3.37 [2.65-4.27],1.6444746681594133e-23
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,41710,326,3.90 [3.40-4.47],2.3586534030365067e-85
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,35859,278,6.13 [5.01-7.50],1.5481359920554165e-69
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,35197,269,1.10 [0.84-1.43],0.485334437007199
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,41195,324,4.56 [3.63-5.74],1.9241582034780353e-38
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,41195,324,1.03 [0.75-1.41],0.8502973794322495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,35707,278,2.69 [1.88-3.87],7.32758954185818e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,41603,324,1.19 [0.98-1.44],0.0778957757417046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,39677,312,1.25 [0.90-1.72],0.1776857365857666
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,41247,323,1.01 [0.61-1.69],0.95439001244162
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,41247,323,0.80 [0.53-1.20],0.2772945479976522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,35796,277,1.17 [0.93-1.48],0.1724981707798424
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,35790,277,1.04 [0.64-1.69],0.8888906653756439
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,34602,264,0.98 [0.81-1.19],0.8440550203792897
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,34602,264,0.99 [0.73-1.33],0.9356028549201292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,35641,278,0.97 [0.83-1.15],0.7622497228385742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,40301,312,1.13 [0.96-1.32],0.1450329015453356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,41351,323,0.98 [0.87-1.10],0.7295746807034169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,35707,278,1.00 [0.89-1.11],0.9411176539333612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,40937,319,1.50 [1.26-1.78],3.444972465911354e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,39853,315,1.02 [0.79-1.31],0.8967943764721387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,41527,324,0.96 [0.82-1.13],0.6544343020399457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,41239,323,1.04 [0.90-1.19],0.6291080506668786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,41239,323,1.32 [1.00-1.75],0.0462371395664604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,35197,269,0.89 [0.59-1.36],0.5942834078449011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,35790,277,0.95 [0.62-1.48],0.8326421002791098
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,41603,324,1.92 [1.50-2.45],1.8397635669641882e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,34760,267,0.96 [0.75-1.24],0.7718698461928372
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,41742,327,1.53 [1.12-2.09],0.0070621724948503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,41239,323,1.23 [0.95-1.59],0.1103494235210542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,40279,316,1.11 [0.88-1.39],0.3749145876182578
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,41045,321,0.95 [0.83-1.09],0.4698801377575499
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,41239,323,0.95 [0.74-1.22],0.706702045189825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,34602,264,1.37 [0.99-1.88],0.0560542037624396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,35805,276,1.03 [0.85-1.25],0.7337080532613771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,34760,267,1.08 [0.88-1.34],0.4452100744730292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,41045,321,1.00 [0.91-1.10],0.983691046889776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,41045,321,1.03 [0.93-1.15],0.5434191064770098
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,41045,321,0.94 [0.69-1.28],0.6773896607906219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,41274,322,0.64 [0.45-0.92],0.0171512950729216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,41576,323,1.16 [0.93-1.46],0.1957935627520217
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,41286,323,0.93 [0.60-1.42],0.725985295252692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,35707,278,1.11 [0.96-1.29],0.1458127113747841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,35197,269,0.99 [0.83-1.17],0.8992903977859624
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,35707,278,1.50 [1.14-1.96],0.00346460091775
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,35197,269,1.29 [1.03-1.61],0.0246967585706945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,41195,324,1.34 [1.21-1.49],4.50836307041011e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,40301,312,1.00 [0.81-1.24],0.9758102996470625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39761,309,1.00 [0.85-1.18],0.9816379865908744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,35864,278,1.27 [0.96-1.67],0.093975741919552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40502,311,1.27 [1.05-1.55],0.015047258480515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,34825,269,1.42 [1.15-1.77],0.0012848983826052
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,40502,311,1.21 [0.94-1.55],0.13042991530604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,35864,278,1.07 [0.89-1.29],0.4566794256605688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,41673,327,1.06 [0.90-1.25],0.4797199394601241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,35096,275,0.91 [0.60-1.37],0.6491345713425677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,34825,269,1.13 [0.81-1.58],0.4691508392724886
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,34760,267,1.02 [0.84-1.24],0.8406051101499746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,35197,269,1.35 [1.12-1.63],0.0014668248321538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,35197,269,1.11 [0.96-1.29],0.162373894639576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,34731,268,1.08 [0.84-1.37],0.5487167668253026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,34602,264,1.06 [0.81-1.38],0.6866703250449586
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,40496,312,1.18 [1.05-1.34],0.0073385631712103
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,34908,268,1.02 [0.88-1.19],0.7581635095707369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,40301,312,1.08 [0.95-1.23],0.2579139122714077
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,35197,269,0.86 [0.67-1.09],0.2067820813385968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,34602,264,1.03 [0.75-1.41],0.8429537927167001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,40183,308,1.07 [0.92-1.24],0.3772160437407688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,40301,312,1.17 [1.00-1.36],0.0437036851715847
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,40279,316,0.98 [0.83-1.15],0.8079858424649909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,41331,326,0.80 [0.70-0.90],0.0004235922665246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,41045,321,0.78 [0.65-0.95],0.0120630896799308
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,41045,321,0.70 [0.60-0.83],2.675842662757791e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,40279,316,1.05 [0.91-1.21],0.5192843784490091
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,35707,278,1.02 [0.88-1.18],0.795701707851268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,35262,273,1.38 [0.96-1.98],0.0786022362870363
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,40301,312,1.35 [1.12-1.63],0.0014263606420106
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,35912,278,1.10 [0.63-1.93],0.7328436312299207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,33839,266,1.25 [0.75-2.09],0.388207397008566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,35656,278,1.31 [1.05-1.63],0.0169944066157563
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,35846,277,1.14 [0.97-1.34],0.1177751311035006
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,35416,275,1.27 [0.96-1.70],0.097212246158217
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,35912,278,1.16 [0.65-2.07],0.6150898965344556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFP,Properdin,35912,278,1.13 [0.70-1.83],0.6154776573224985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,41247,323,1.13 [0.98-1.30],0.0952460759372714
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,35885,280,1.00 [0.75-1.34],0.9859653004732049
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,34892,262,1.02 [0.76-1.37],0.8701890856190402
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,41239,323,1.06 [0.84-1.33],0.635270018763977
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,40301,312,1.18 [1.01-1.39],0.0343766069956757
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,35096,275,0.79 [0.63-0.99],0.0394218286873324
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",35790,277,1.79 [1.44-2.24],2.348361859458057e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,35697,278,1.62 [1.19-2.20],0.0022370054174845
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,40502,311,1.06 [0.79-1.44],0.6848312732303612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,35864,278,1.23 [1.10-1.37],0.0002532689351566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,41461,323,1.08 [0.85-1.37],0.5455106533754779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,40330,313,1.08 [0.95-1.22],0.2262215060658485
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,41420,326,1.00 [0.94-1.06],0.8774068662988183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,41326,323,0.96 [0.70-1.33],0.8258528900445025
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,34892,262,1.01 [0.83-1.22],0.9418212665916588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,40937,319,1.04 [0.92-1.18],0.5502173283204097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,35859,278,0.94 [0.77-1.15],0.5657468598827693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,34760,267,1.03 [0.89-1.21],0.6632208465450278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,41341,322,1.43 [1.04-1.95],0.0266885594173922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,41239,323,0.98 [0.81-1.20],0.8730765841439754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,34892,262,1.00 [0.72-1.39],0.9958900672716812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,41351,323,1.01 [0.86-1.18],0.9488450663680612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,35864,278,0.98 [0.79-1.20],0.8227485015188527
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,35197,269,1.01 [0.78-1.31],0.9547980163264712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,35707,278,1.03 [0.92-1.17],0.5886840530051534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,34892,262,1.63 [1.35-1.96],3.234816810592116e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,41509,324,2.40 [1.87-3.08],6.322449707245753e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,35864,278,1.61 [1.33-1.95],1.1948386251184089e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",41074,321,0.89 [0.78-1.02],0.0860262913603427
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,34602,264,0.96 [0.81-1.13],0.619187967344399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,41174,322,0.90 [0.78-1.05],0.1950441351004862
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,40937,319,1.40 [1.06-1.84],0.0172735208999016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,41171,323,1.18 [0.96-1.45],0.1146171664807063
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,34825,269,2.85 [2.03-4.01],1.634215197198724e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,41247,323,1.50 [1.11-2.03],0.0081097735531392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,40502,311,1.73 [1.29-2.32],0.0002158039058135
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,41603,324,1.02 [0.92-1.13],0.675123105279723
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,34892,262,0.93 [0.73-1.19],0.5838184011121923
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,35074,271,0.51 [0.29-0.89],0.0179408750915825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,41195,324,0.88 [0.67-1.16],0.3644760992732845
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,41195,324,1.38 [1.12-1.69],0.0022420601785455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,41195,324,1.17 [1.00-1.37],0.0498848236324752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,41195,324,1.71 [1.28-2.29],0.0003017679307518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,35802,277,0.80 [0.63-1.01],0.0661878596442424
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,41111,322,1.76 [1.28-2.41],0.0004877451564446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,40301,312,1.81 [1.50-2.19],3.947331253420312e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,41710,326,1.36 [1.11-1.67],0.0028691127652863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,34892,262,1.23 [0.97-1.57],0.0936880476812461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,34892,262,0.95 [0.65-1.39],0.7968690034213615
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,34602,264,0.97 [0.75-1.25],0.7969345870863784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,41195,324,1.00 [0.92-1.10],0.911991141489824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,41611,321,1.49 [0.94-2.38],0.0918680715190903
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,34892,262,1.00 [0.70-1.41],0.981033229021465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40861,319,1.04 [0.94-1.16],0.4325008730832338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,41174,323,1.18 [1.02-1.35],0.0208873778523884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,40203,316,1.06 [0.81-1.38],0.6918864896199441
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,40279,316,0.97 [0.80-1.18],0.7895382016300545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,41710,326,1.00 [0.78-1.29],0.9976442839736268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,35790,277,2.60 [2.02-3.35],1.0535178781247132e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,40502,311,1.17 [0.96-1.43],0.130305780437383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,35912,278,1.03 [0.71-1.50],0.8799501311331098
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,41174,323,0.76 [0.61-0.95],0.0155932034169418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,35859,278,0.99 [0.87-1.12],0.8551129899289505
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,35697,278,1.01 [0.88-1.16],0.872624869416313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,41390,323,0.80 [0.65-0.98],0.0333876622538266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,34760,267,0.84 [0.65-1.08],0.1666221735810862
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",34842,267,1.07 [0.92-1.24],0.3720966415611902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,40502,311,0.97 [0.81-1.15],0.6975059486677309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,41045,321,1.01 [0.88-1.15],0.927013092477602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNST,Consortin,41239,323,0.98 [0.89-1.07],0.6515409479126328
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,34760,267,0.97 [0.69-1.37],0.8784482964322919
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,41742,327,0.92 [0.65-1.32],0.6571414818440742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,41611,321,1.10 [0.89-1.37],0.3769295535971179
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,41247,323,0.50 [0.37-0.68],7.698528245321117e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,41247,323,0.59 [0.39-0.89],0.012469853713413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,41340,324,0.82 [0.63-1.08],0.155278129489211
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,41195,324,1.13 [0.89-1.43],0.3002192419211078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,34892,262,1.07 [0.97-1.19],0.1826145257786163
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,35859,278,1.47 [1.16-1.85],0.0013672574576386
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,35864,278,0.86 [0.56-1.33],0.4923824977082074
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,41409,325,1.93 [1.27-2.93],0.0020025486033329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,41742,327,0.74 [0.50-1.10],0.1340849746863129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,35707,278,1.13 [0.92-1.39],0.2538759701380915
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,34892,262,0.94 [0.81-1.10],0.4773728201432304
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,34908,268,1.04 [0.90-1.21],0.5632103724376898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,35864,278,1.04 [0.63-1.69],0.8907870974167081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,41239,323,1.54 [1.21-1.96],0.0004262555211816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,35136,268,0.88 [0.71-1.08],0.2153712592773463
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,35096,275,1.23 [0.93-1.64],0.1480252005944933
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,41742,327,1.55 [1.18-2.02],0.0013896160688925
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,41195,324,1.08 [0.88-1.33],0.4360255071887651
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,35197,269,1.12 [0.88-1.41],0.3581308009906389
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,41202,322,1.83 [1.27-2.64],0.0012286088264648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,34908,268,1.14 [0.94-1.38],0.1728196344810188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,35697,278,1.15 [0.88-1.50],0.315642102843814
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,40800,320,0.75 [0.56-1.01],0.0557562537482009
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,40066,307,1.08 [0.95-1.22],0.2318275961193456
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',34731,268,0.96 [0.73-1.26],0.763237897790674
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,40279,316,0.95 [0.76-1.19],0.6707547495952577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",34908,268,1.00 [0.77-1.31],0.9958081934103
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,40385,315,1.04 [0.94-1.16],0.4517888366509668
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,34760,267,1.12 [0.82-1.52],0.469120749351083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",41045,321,1.08 [0.94-1.24],0.2947019594029337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,35859,278,1.20 [0.85-1.69],0.2928841334464994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,41742,327,1.05 [0.90-1.23],0.5540661930988762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,41463,323,1.04 [0.90-1.21],0.563142768150982
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,34400,269,1.07 [0.82-1.41],0.6068238891623903
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,41742,327,1.09 [0.93-1.28],0.2937369300520626
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,35840,275,0.86 [0.51-1.43],0.5547573730879738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,41289,321,0.88 [0.69-1.13],0.3120863253800599
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,34602,264,0.83 [0.56-1.24],0.3559737882323308
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,41408,322,0.97 [0.73-1.29],0.8276177617047309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",34825,269,0.98 [0.64-1.50],0.9270194398955258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,41603,324,1.05 [0.91-1.21],0.5273589692199145
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,35795,278,1.11 [0.80-1.53],0.5284770004736598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,34731,268,1.14 [0.86-1.50],0.3700406490715416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,41548,321,1.33 [1.03-1.70],0.0264148809697734
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,41351,323,1.07 [0.93-1.23],0.3403684006276307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,35859,278,1.39 [0.91-2.13],0.1256296273748097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,35747,279,2.31 [1.70-3.15],8.625805643195727e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,41390,323,2.38 [1.95-2.90],1.0862673534057977e-17
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,40301,312,1.07 [0.95-1.20],0.2716001054596622
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,40861,319,1.06 [0.93-1.21],0.3936533727458452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,34602,264,0.81 [0.64-1.03],0.0892893047152453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,34602,264,0.76 [0.47-1.22],0.2494727106551905
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,40695,319,1.07 [0.83-1.38],0.6167335567889113
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,35096,275,1.27 [0.93-1.73],0.1327595065704356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,41341,322,1.13 [0.94-1.36],0.1991307272239953
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,40234,312,1.15 [1.02-1.29],0.0201274760411185
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,41202,322,1.16 [0.81-1.66],0.4060055548089695
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,40502,311,1.04 [0.88-1.21],0.6664904567682044
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,41402,323,2.00 [1.24-3.22],0.0042249872021381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,40937,319,1.15 [0.89-1.49],0.2836834297097996
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,41611,321,1.07 [0.90-1.27],0.4642127829109813
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,35550,279,1.13 [0.74-1.73],0.5701324088687061
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,41273,322,0.99 [0.90-1.09],0.8671325560746576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,41402,323,1.18 [0.79-1.74],0.4202095047915335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,40066,311,1.06 [0.91-1.23],0.4616389371638085
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,41742,327,0.75 [0.55-1.03],0.0740038950514917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,40937,319,3.05 [2.56-3.64],3.9752981693187535e-35
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,34892,262,0.95 [0.74-1.22],0.7028584959844655
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,40502,311,1.01 [0.92-1.10],0.8753724439240166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,35859,278,1.13 [0.95-1.35],0.1694790222162159
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,35790,277,0.99 [0.85-1.16],0.9061938991354288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,35790,277,0.98 [0.87-1.10],0.7310719064403286
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,34760,267,1.11 [0.96-1.28],0.1660264582675004
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,34908,268,1.03 [0.90-1.17],0.7056281726115081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,34731,268,1.08 [0.98-1.18],0.1160015146836303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,41402,323,3.03 [2.18-4.22],3.576739963270715e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,35885,280,1.77 [1.38-2.28],8.58203471015426e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,34731,268,0.74 [0.52-1.05],0.089104431522438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40937,319,1.31 [1.14-1.52],0.0001937569476626
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,34825,269,1.82 [1.38-2.40],1.966851982333125e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,40496,312,1.20 [0.98-1.47],0.0756873221060719
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,34825,269,1.50 [1.06-2.10],0.0205315887670365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,35885,280,0.88 [0.59-1.31],0.5386547899768764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,34825,269,1.17 [0.99-1.39],0.0668880503006935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,35805,276,1.04 [0.81-1.35],0.7495461880721546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,35864,278,0.99 [0.70-1.41],0.962351861423088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,34760,267,1.09 [0.87-1.36],0.4718928061840424
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,34731,268,1.09 [0.98-1.22],0.1193797885124543
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,31136,250,0.95 [0.84-1.07],0.3794961257621984
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,41322,323,1.83 [1.32-2.55],0.0002985890219538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,40473,316,1.16 [0.97-1.38],0.1029173202278258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,40183,314,0.90 [0.73-1.11],0.3259235131664457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,41275,322,1.15 [1.05-1.25],0.0018679424209659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,40671,317,1.39 [1.11-1.74],0.0039922354201121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,35127,269,1.03 [0.81-1.30],0.8199292047426175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,35367,277,1.25 [0.81-1.94],0.3143633195983084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,40502,311,1.00 [0.89-1.12],0.969094312439516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,35864,278,1.38 [0.93-2.06],0.1076457086758477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,35864,278,1.13 [0.79-1.62],0.4886649848022534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,34760,267,0.74 [0.49-1.10],0.1355693150382336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,41247,323,1.08 [0.91-1.29],0.3790139970091369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,41210,321,1.10 [0.94-1.28],0.2310168471563089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,35790,277,1.14 [0.97-1.35],0.1223224109704094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,41265,325,1.24 [1.03-1.48],0.0204153146025556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,41130,319,1.17 [0.94-1.45],0.1682275551304426
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,38521,302,1.05 [0.81-1.35],0.7290878367559136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,35096,275,1.00 [0.80-1.25],0.9971081568856688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,41351,323,1.00 [0.78-1.28],0.9955915980875818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,40376,309,1.19 [1.04-1.37],0.0107230279038269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,41239,323,2.32 [1.58-3.39],1.5484979234812977e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,41710,326,1.74 [1.28-2.35],0.0003470053012261
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,32456,253,2.19 [1.34-3.56],0.0016500356284807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,41483,321,0.63 [0.49-0.81],0.0003113711205325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,41251,321,1.87 [1.38-2.54],6.268187346918815e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,34892,262,0.97 [0.71-1.34],0.8648375971456038
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,35497,277,1.30 [1.13-1.49],0.0003199152808898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,40937,319,1.38 [1.03-1.84],0.0294056296281897
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,41195,324,1.22 [1.01-1.47],0.0344833130905022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,41147,321,1.00 [0.90-1.11],0.954757749779368
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,41402,323,1.27 [1.12-1.45],0.0003319991969909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,41603,324,1.29 [1.16-1.43],1.393174633883994e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,40496,312,1.30 [1.01-1.66],0.0384527370499658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,41603,324,1.71 [1.61-1.81],4.5254287991831554e-73
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,40496,312,1.02 [0.87-1.21],0.7832737813650426
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,41672,327,0.51 [0.33-0.78],0.0019854586987988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,41710,326,1.25 [1.00-1.57],0.051475187920151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,41214,321,0.95 [0.86-1.05],0.3184633046599636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,41104,323,0.95 [0.88-1.04],0.2754089705964459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,41710,326,1.09 [0.96-1.24],0.16536088023273
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,40956,321,1.12 [0.99-1.28],0.0798662735856665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,41402,323,1.72 [1.55-1.92],4.661997071027583e-23
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,34602,264,0.98 [0.83-1.16],0.8218479440393229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,35298,275,1.35 [1.11-1.64],0.0021876528881974
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",34731,268,1.05 [0.92-1.19],0.493153632125178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,34602,264,0.98 [0.83-1.16],0.838087896837045
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,35864,278,0.64 [0.40-1.03],0.0637853587596379
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,35096,275,0.94 [0.82-1.09],0.418115917904525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,41611,321,0.97 [0.89-1.06],0.5696760178595632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,41402,323,1.02 [0.83-1.26],0.8484590432591295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,34825,269,1.12 [0.92-1.36],0.2576357202010773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,34825,269,1.20 [1.00-1.44],0.0493489898282413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,41195,324,1.00 [0.92-1.08],0.930517459802262
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",40861,319,1.03 [0.90-1.18],0.7126968922353929
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,35822,279,1.00 [0.90-1.11],0.96432475648659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,41057,319,1.04 [0.91-1.18],0.5916837872014717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,34825,269,1.16 [0.93-1.45],0.1952782474243897
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,41402,323,1.00 [0.90-1.11],0.9917320517325364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",41351,323,1.30 [0.98-1.72],0.0659405994288715
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,34892,262,0.74 [0.41-1.32],0.3105297674833824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,34602,264,0.82 [0.66-1.01],0.0559475540884367
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,34602,264,0.97 [0.66-1.43],0.8951770948917139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCN,Decorin,40502,311,1.35 [0.87-2.08],0.1788317682332391
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,35096,275,1.01 [0.89-1.14],0.9353715549710212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,41611,321,0.99 [0.85-1.15],0.8767677203102986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,41045,321,1.01 [0.91-1.12],0.8923629317616151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,40279,316,1.07 [0.93-1.22],0.3405122945377094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,41239,323,3.28 [2.49-4.32],3.892416620399517e-17
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,34760,267,1.12 [0.97-1.29],0.1102467929225021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,34602,264,0.96 [0.83-1.12],0.6204912337658617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,41351,323,0.94 [0.78-1.14],0.5454569981894066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,34731,268,1.17 [0.89-1.53],0.2550901132184886
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",41045,321,1.09 [0.87-1.35],0.4558651741081166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,41184,322,0.98 [0.80-1.21],0.8807277727730528
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,35805,276,1.02 [0.86-1.22],0.815942731318908
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,35096,275,1.02 [0.88-1.19],0.7579502643627518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,41603,324,1.63 [1.07-2.47],0.0224420596561899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,35864,278,1.22 [0.94-1.59],0.1311148924336536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,35707,278,1.16 [0.94-1.43],0.155280958722548
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,34892,262,1.01 [0.74-1.39],0.948712397967642
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,34825,269,1.06 [0.65-1.74],0.8116752836383864
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,34825,269,0.98 [0.79-1.23],0.8874033388967061
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,34892,262,0.82 [0.58-1.15],0.240491296223246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,40301,312,1.26 [1.08-1.45],0.0023031662623853
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",41195,324,0.99 [0.89-1.09],0.7941041447117909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,40413,318,1.34 [1.15-1.57],0.0002460511454412
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,34564,267,1.16 [0.90-1.48],0.2474734101944087
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,34760,267,0.84 [0.66-1.06],0.1380385593160381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,34760,267,0.98 [0.84-1.15],0.8512668564171919
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,34760,267,1.07 [0.88-1.29],0.4987680717849518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,40643,319,1.08 [1.01-1.15],0.0277791451632451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,34731,268,0.83 [0.63-1.09],0.1874029757943334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,34825,269,0.90 [0.73-1.12],0.350457030867723
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,41710,326,1.08 [0.94-1.25],0.2667702788446154
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,34760,267,1.25 [1.01-1.55],0.041347888581582
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,34825,269,1.07 [0.86-1.32],0.5601013484059871
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,40496,312,1.16 [0.88-1.53],0.3080613765926718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,34731,268,1.17 [0.94-1.45],0.1607809885516973
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,35697,278,1.47 [1.21-1.80],0.0001311430772824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,35790,277,0.98 [0.77-1.26],0.8990522570196368
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",41111,322,0.94 [0.86-1.03],0.2096066209110698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,34892,262,1.23 [0.96-1.58],0.1028458035961718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,35096,275,0.97 [0.64-1.48],0.8991333871639693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,41603,324,1.15 [0.97-1.35],0.1033243288797896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,41742,327,0.96 [0.69-1.33],0.7912136466705725
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,40873,319,1.01 [0.82-1.26],0.9057738309837255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,41045,321,1.10 [0.98-1.24],0.1220859549664552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,35790,277,0.99 [0.85-1.17],0.9466444383653728
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,35805,276,1.02 [0.82-1.27],0.8389415145897845
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,41742,327,0.98 [0.82-1.16],0.7883559893025075
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,41351,323,2.80 [2.07-3.78],1.9489902627371388e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,34908,268,0.96 [0.83-1.11],0.5794458989608477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,34908,268,1.15 [0.92-1.43],0.2139695150971496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,34908,268,0.91 [0.76-1.10],0.3450070627979152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,34602,264,0.96 [0.74-1.26],0.7899945028436215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,41583,325,0.97 [0.86-1.10],0.6584678787004266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,35790,277,1.10 [0.94-1.29],0.2349344566088984
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,41045,321,1.03 [0.92-1.16],0.5993114719211646
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,35707,278,1.14 [0.96-1.35],0.1468389370992927
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,35096,275,0.99 [0.80-1.22],0.9037897120207024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,34761,273,1.00 [0.87-1.15],0.9576723353575488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,40502,311,1.09 [0.93-1.28],0.289440748262383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,35790,277,1.28 [0.97-1.68],0.0837343225909145
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,34908,268,1.04 [0.90-1.20],0.5843074383390692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,35707,278,1.08 [0.93-1.25],0.3075304176652181
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,41140,321,0.52 [0.36-0.77],0.0011087613165344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,34760,267,1.08 [0.96-1.22],0.1801342183873184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,35707,278,0.94 [0.85-1.04],0.2584091319410265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,35805,276,1.06 [0.86-1.30],0.5719970632922736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,40937,319,1.13 [0.96-1.32],0.1358718488934771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,35790,277,0.94 [0.77-1.15],0.5466507693644392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,41334,323,1.00 [0.83-1.21],0.9595934800963692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,34892,262,1.22 [0.93-1.60],0.1541276423685825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,34760,267,0.99 [0.90-1.10],0.8756307769027255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,35790,277,1.00 [0.92-1.09],0.9902922223050136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,41239,323,0.99 [0.91-1.07],0.7471635396397083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,40861,319,1.14 [0.93-1.40],0.2158521289867686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,41045,321,1.15 [0.82-1.61],0.4080250238864307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,41195,324,0.99 [0.75-1.32],0.9684082587272598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,40468,316,0.52 [0.37-0.74],0.0001960276045826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,41045,321,0.80 [0.59-1.07],0.1268521084737365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,40910,321,1.10 [0.93-1.29],0.2739737052404094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,41742,327,1.37 [0.93-2.03],0.1107207911448769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,41487,321,1.28 [1.11-1.49],0.0010202168852439
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,40937,319,1.41 [1.12-1.77],0.0033475623093788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,41045,321,1.00 [0.84-1.19],0.9610853182951812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,40771,321,2.37 [1.86-3.01],1.7503842774937166e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,35805,276,1.36 [0.99-1.87],0.0599565267248574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,41247,323,1.18 [0.83-1.70],0.357859768230321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,41484,321,1.13 [0.85-1.51],0.4063202554059486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,40900,321,0.94 [0.77-1.15],0.5687842177440113
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,35096,275,0.97 [0.85-1.11],0.6430077232460676
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,35631,278,1.44 [1.13-1.83],0.0032992010660249
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,34892,262,0.97 [0.80-1.18],0.784721381385552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,41045,321,1.94 [1.32-2.83],0.0006464591924633
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,35859,278,1.07 [0.90-1.26],0.4555390867520138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,40502,311,0.96 [0.83-1.11],0.5605516041734833
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,35697,278,0.73 [0.55-0.98],0.0376047085920046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,34892,262,1.04 [0.88-1.24],0.6292889280859423
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,40279,316,0.95 [0.84-1.07],0.4104015984318859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",35707,278,1.04 [0.93-1.16],0.4895632712002353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,35790,277,1.29 [1.01-1.64],0.0446524803224433
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,35697,278,1.05 [0.83-1.32],0.713282539052068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,34892,262,1.13 [0.99-1.30],0.0776126317238898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,35697,278,1.14 [0.88-1.47],0.323664838761726
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40937,319,1.02 [0.92-1.14],0.6586165563111861
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,41549,321,2.85 [2.18-3.73],1.7606075092485576e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,40279,316,0.92 [0.69-1.23],0.5789615932810804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",35859,278,1.10 [0.95-1.28],0.2156777956011028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",34908,268,1.09 [0.97-1.23],0.1487896018279781
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,34731,268,1.13 [0.94-1.35],0.1967541105059894
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,34920,269,0.92 [0.68-1.26],0.6151336675752295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,34760,267,0.84 [0.65-1.09],0.19455348368032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,41611,321,1.97 [1.54-2.52],6.14324140516202e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,41195,324,0.87 [0.78-0.97],0.0112133407732643
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,35697,278,0.89 [0.71-1.11],0.3011485845288209
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,34731,268,0.80 [0.56-1.15],0.2281745860584835
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,35805,276,1.10 [0.94-1.28],0.2482381577089364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40502,311,0.99 [0.74-1.33],0.9554688342041324
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,34908,268,1.60 [1.07-2.37],0.0209978054601698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,34825,269,1.39 [1.15-1.68],0.0005982212121269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,35859,278,1.06 [0.94-1.20],0.331803344662626
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,35707,278,1.67 [1.26-2.21],0.0003321873091019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,35197,269,1.13 [0.82-1.57],0.4505911217224287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,41321,323,1.12 [0.81-1.53],0.4956554004714092
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,35805,276,1.16 [0.85-1.59],0.3486165603483414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,41179,320,1.77 [1.27-2.47],0.0007761568039138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,40867,318,3.44 [2.66-4.46],6.599893472288261e-21
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,34892,262,0.95 [0.77-1.18],0.6617356857121364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,41151,321,1.00 [0.91-1.10],0.9880414123103792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,40301,312,1.57 [1.26-1.96],5.783386831723652e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,35707,278,1.15 [0.80-1.66],0.4420476815177311
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,41742,327,0.35 [0.19-0.63],0.000521040409515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,41195,324,1.28 [1.12-1.46],0.000357041657677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,35859,278,1.01 [0.87-1.18],0.897991381974436
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,34908,268,0.96 [0.86-1.06],0.3698227789901649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",35790,277,1.08 [0.89-1.32],0.4251368526746613
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",35583,278,1.04 [0.94-1.15],0.4696909073153097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,34731,268,0.98 [0.81-1.17],0.8040226095664285
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,34908,268,1.19 [0.92-1.55],0.1782169359265366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,40937,319,1.09 [0.91-1.29],0.3498527229142839
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,34825,269,0.99 [0.87-1.13],0.8935490309007763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,41239,323,1.12 [0.96-1.29],0.1477547887974155
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,41710,326,1.01 [0.92-1.12],0.826788791110165
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,35805,276,0.96 [0.80-1.14],0.6181096109345539
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,34731,268,1.07 [0.83-1.39],0.5903702839695975
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,40496,312,1.08 [0.77-1.50],0.6637886416341461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,35805,276,1.08 [0.95-1.24],0.2415886996054189
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,34760,267,1.00 [0.87-1.15],0.9811032509478452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELN,Elastin,35859,278,1.40 [1.01-1.93],0.0445516265116457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,41045,321,1.25 [1.08-1.44],0.002877416096491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,34731,268,1.06 [0.79-1.42],0.6853186146238819
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,40496,312,1.11 [0.91-1.37],0.3033060800299308
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,33104,257,0.81 [0.64-1.02],0.0675536800239979
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,41742,327,1.92 [1.10-3.35],0.0218661124641461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,41188,321,1.00 [0.88-1.13],0.9722713982668156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,41603,324,0.96 [0.82-1.11],0.568092180273486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,34908,268,0.80 [0.64-0.99],0.0379715099676985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,35697,278,0.95 [0.76-1.18],0.6294393526454778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,34731,268,1.24 [0.83-1.85],0.2909282106869469
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,34731,268,0.77 [0.55-1.06],0.1115748082963633
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,41742,327,1.61 [1.13-2.29],0.0077202449046369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,41402,323,0.83 [0.68-1.02],0.076483788276798
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,34908,268,0.81 [0.59-1.12],0.1976206140856698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39948,308,0.96 [0.85-1.08],0.5049228743055159
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,35697,278,1.06 [0.86-1.31],0.598228561884271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,40301,312,0.94 [0.74-1.18],0.5855466696708029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40502,311,1.32 [0.82-2.13],0.2459792613562906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40502,311,1.06 [0.73-1.53],0.7661774950233035
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,34908,268,1.01 [0.83-1.23],0.9379910330626456
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,34825,269,1.20 [0.85-1.69],0.2948727271496599
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,34892,262,0.89 [0.73-1.10],0.2840944397033398
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,41201,322,1.03 [0.93-1.14],0.576783422716586
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,35697,278,0.98 [0.76-1.26],0.8563111071811856
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,41334,323,1.31 [0.97-1.78],0.0804933583304811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,40279,316,1.06 [0.92-1.22],0.4116169424464798
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,39783,312,2.16 [1.69-2.78],1.4158739756058112e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,35096,275,1.78 [1.19-2.66],0.0049674084258986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,41742,327,1.87 [1.28-2.71],0.0010787847582128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,40861,319,2.56 [1.90-3.45],5.951409030594465e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,40502,311,1.10 [0.94-1.27],0.2351791417922031
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,35197,269,1.05 [0.81-1.36],0.7182567020079351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,41195,324,1.31 [1.18-1.46],7.47765824963588e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,34908,268,1.15 [0.99-1.35],0.0695663192515527
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,41549,321,1.28 [0.93-1.77],0.1309617524902257
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,41351,323,0.56 [0.38-0.82],0.0030519225374988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,41079,321,0.65 [0.39-1.09],0.1005752932396748
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,41351,323,0.62 [0.41-0.93],0.021316629203662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,41045,321,1.00 [0.90-1.10],0.9215259542715556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,34892,262,1.03 [0.88-1.20],0.7083306887290075
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,34602,264,0.99 [0.70-1.42],0.971798899298627
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,40861,319,1.02 [0.90-1.16],0.7337036760007105
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,35197,269,1.53 [1.14-2.05],0.0045953875272984
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,34825,269,1.19 [0.92-1.55],0.1863736243945903
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,35697,278,0.90 [0.66-1.23],0.5130004078085033
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,35096,275,0.98 [0.89-1.08],0.7200794033858368
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,40979,321,0.75 [0.51-1.11],0.147878407238906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,34731,268,0.95 [0.73-1.25],0.7327296346101791
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,41742,327,1.33 [0.98-1.79],0.0663786518455093
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,41202,322,1.27 [0.95-1.69],0.1062209890331794
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,34602,264,1.10 [0.91-1.34],0.3084241599835171
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,34825,269,1.23 [1.04-1.45],0.0157403178932882
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,35790,277,1.06 [0.92-1.22],0.4221203885020785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,34602,264,0.90 [0.65-1.23],0.5036686640141783
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,34825,269,0.96 [0.84-1.10],0.5481046292206908
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,35197,269,0.98 [0.69-1.40],0.926961263893071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,34731,268,1.08 [0.90-1.30],0.3932386356676743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,34731,268,1.00 [0.78-1.27],0.9683491411959534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,41603,324,2.44 [1.70-3.51],1.439330274622669e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,35885,280,0.81 [0.54-1.23],0.3206850312543603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,35394,272,0.90 [0.61-1.34],0.6057872932226733
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,41247,323,1.01 [0.85-1.21],0.8703559943597895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,35912,278,0.85 [0.65-1.12],0.2481577855185739
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,35723,274,0.93 [0.59-1.46],0.745429719143716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,35912,278,1.03 [0.48-2.20],0.9373483063693548
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,41341,322,1.10 [0.92-1.30],0.2843653372687631
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,41356,321,1.25 [0.87-1.79],0.2316066239867833
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,41331,322,0.84 [0.61-1.15],0.2723225697054188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,41330,322,0.93 [0.54-1.60],0.7823767049200678
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",41202,322,1.14 [1.03-1.26],0.0106576154838612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",41239,323,1.15 [1.02-1.30],0.0239127446086983
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",35859,278,1.27 [1.03-1.57],0.0247300050976506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",41742,327,1.08 [0.89-1.32],0.4355681957687511
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,41473,321,1.05 [0.91-1.21],0.5003862842657275
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,40439,311,1.10 [0.93-1.31],0.265863641152959
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,41195,324,1.03 [0.87-1.23],0.7124881016772976
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,41239,323,1.00 [0.88-1.14],0.97004564059249
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,35707,278,1.01 [0.85-1.20],0.892258852440403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,35805,276,0.97 [0.90-1.05],0.4241512504510329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,35697,278,1.34 [0.94-1.90],0.1008029548782184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,34908,268,1.09 [0.90-1.32],0.3651506013234614
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,35859,278,1.03 [0.68-1.54],0.9042401926659004
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,41045,321,1.13 [0.85-1.50],0.4117630826582641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,41184,322,1.50 [1.08-2.08],0.0144984771752073
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,35707,278,1.02 [0.90-1.17],0.720432419966752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,41742,327,0.57 [0.40-0.82],0.0020223052100514
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,34892,262,1.08 [0.92-1.27],0.3528150195656661
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,41613,326,1.40 [1.13-1.74],0.0021796136157293
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,41710,326,1.15 [0.88-1.51],0.290137164005334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,35864,278,1.45 [1.01-2.08],0.0460105733037668
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,34892,262,1.19 [0.98-1.45],0.0838314622299126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",41239,323,0.93 [0.81-1.07],0.3177459755605912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,35859,278,2.26 [1.98-2.59],3.3620849284596725e-33
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,41195,324,1.15 [0.93-1.41],0.1887193567453693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,35805,276,0.97 [0.60-1.58],0.9154168653205588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,41247,323,2.47 [2.16-2.84],2.025466421647867e-38
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,41064,318,1.15 [0.96-1.38],0.1342942040201457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,40301,312,1.10 [0.93-1.30],0.2720029477677363
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,41265,322,1.06 [0.87-1.30],0.5456600378410689
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,35822,279,1.16 [0.93-1.44],0.1874246930345549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,41051,321,1.21 [0.94-1.55],0.1437747070850625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,41239,323,2.90 [2.43-3.45],1.0593596849940768e-32
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,41516,323,3.10 [2.78-3.46],1.438048794490299e-90
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,40496,312,2.28 [1.94-2.68],4.2328946757167325e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,41247,323,1.51 [1.28-1.79],1.5871246081757616e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,41195,324,1.32 [1.14-1.53],0.0001725153511625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,40301,312,1.48 [1.32-1.67],1.6053600674616657e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",34731,268,1.10 [0.93-1.31],0.2609430872047271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",34731,268,1.10 [0.91-1.34],0.3363989034911023
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,40301,312,1.11 [0.97-1.27],0.1221202217065967
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,40301,312,0.96 [0.77-1.19],0.7185451751372571
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,41330,322,1.13 [0.83-1.55],0.4214520458029204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,35075,273,1.59 [1.10-2.30],0.0141636647668367
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",35805,276,1.06 [0.92-1.23],0.3880085094571326
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,34825,269,1.07 [0.85-1.34],0.5614808953634702
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,34825,269,1.12 [0.89-1.41],0.3457512629643164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,41402,323,0.97 [0.85-1.10],0.6088528513417046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,41195,324,1.15 [1.00-1.33],0.0450501377362945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,34825,269,1.17 [0.93-1.47],0.1788071057481477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,41549,321,1.00 [0.92-1.09],0.9826953522321714
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,41549,321,1.18 [1.00-1.39],0.0452659027365403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,34825,269,0.88 [0.58-1.33],0.5372489646986428
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,40496,312,1.08 [0.80-1.46],0.619488526002484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,34825,269,1.12 [0.87-1.45],0.3692554873031525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,34602,264,1.01 [0.87-1.17],0.8854736448348398
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,34537,264,0.95 [0.71-1.28],0.7515732988315325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,41351,323,0.60 [0.45-0.81],0.0007250099449011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,35864,278,0.62 [0.49-0.78],4.813299550742634e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,35790,277,1.10 [0.81-1.51],0.5305722521579594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,41351,323,0.91 [0.58-1.43],0.6757680409396974
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,35096,275,0.93 [0.75-1.16],0.5293225908473467
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,35885,280,1.19 [1.00-1.42],0.05326342465081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,40279,316,1.10 [0.95-1.28],0.2079485653219382
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",34760,267,1.10 [0.98-1.25],0.111646241875737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,34731,268,1.12 [0.89-1.40],0.3301130987328331
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,40279,316,0.97 [0.85-1.12],0.7056778113276385
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,41207,322,0.95 [0.84-1.08],0.4465372590704292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,35805,276,1.02 [0.91-1.15],0.7356374600079267
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,41377,325,0.98 [0.90-1.07],0.6360866555523492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40937,319,1.21 [0.96-1.52],0.1041392152632614
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40937,319,1.04 [0.94-1.16],0.4741004800437997
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,40203,316,1.21 [1.01-1.45],0.0405495498529816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,35707,278,1.00 [0.83-1.22],0.9797732598349456
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,40301,312,1.03 [0.94-1.12],0.5682263521412237
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40937,319,1.85 [1.32-2.58],0.000334636266059
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,40968,321,0.77 [0.48-1.24],0.280974881626531
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,40301,312,1.28 [0.96-1.72],0.0920384396264477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,41710,326,1.41 [1.06-1.89],0.0197565121303178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,41351,323,1.23 [0.92-1.65],0.1697555193163669
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,40279,316,1.10 [0.95-1.26],0.194514174488367
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,40301,312,1.12 [0.84-1.49],0.4322604857500307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,35912,278,0.66 [0.42-1.01],0.0567298983012238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,35790,277,0.80 [0.63-1.02],0.0700313315631714
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,35697,278,1.33 [0.99-1.77],0.0572564694264907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,34825,269,1.08 [0.98-1.19],0.1121154197696809
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,41161,322,1.57 [1.12-2.19],0.0084063007201956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,41603,324,1.63 [1.17-2.26],0.0038806604699144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,41222,323,1.02 [0.98-1.08],0.334289726606278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,34537,264,1.03 [0.74-1.44],0.8390739477507286
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,40279,316,1.25 [1.01-1.54],0.0365650110996641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,34825,269,1.04 [0.80-1.35],0.7558928949398579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,41195,324,1.11 [0.99-1.24],0.0770009279714059
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,40301,312,1.13 [1.02-1.25],0.0152780653558118
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,34731,268,0.94 [0.79-1.12],0.5168439158471718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,34892,262,1.03 [0.73-1.47],0.8502559621228452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,40805,318,1.32 [0.88-1.96],0.1803652173405437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,34908,268,1.42 [1.17-1.71],0.0002728927773503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FST,Follistatin,41341,322,0.87 [0.71-1.07],0.1801802389901385
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,34908,268,2.44 [1.56-3.83],9.793759288394168e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,41138,321,1.51 [1.11-2.05],0.0082604166901757
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,35724,277,0.98 [0.85-1.12],0.723417682895682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,41481,322,1.06 [0.94-1.20],0.3593200657463581
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,35096,275,1.03 [0.86-1.24],0.7510016654580598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FURIN,Furin,41351,323,0.73 [0.54-0.98],0.0363267785672021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,40240,312,1.48 [1.18-1.86],0.0005966842976295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",35127,269,1.12 [0.94-1.33],0.1925437250723071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,41603,324,1.26 [1.02-1.55],0.035716141694105
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",40937,319,1.18 [1.00-1.39],0.0537877621231355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",41611,321,0.98 [0.85-1.12],0.7259074984551952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,40496,312,0.96 [0.82-1.12],0.5673558055581078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,41174,323,0.95 [0.85-1.05],0.3131704646544014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,34892,262,1.04 [0.86-1.26],0.6698130364342354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,34760,267,1.22 [0.97-1.54],0.0890557213368536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,35697,278,1.32 [1.09-1.61],0.0049061069180537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,35197,269,1.10 [0.94-1.29],0.2433364148254386
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,34760,267,1.03 [0.86-1.23],0.7735563903530158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,34602,264,0.93 [0.59-1.46],0.7405676144150104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,34825,269,1.01 [0.78-1.30],0.9535466820605982
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,35197,269,1.19 [0.98-1.43],0.0743215512832011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,34908,268,1.08 [0.87-1.35],0.4819129729457549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,34602,264,1.06 [0.89-1.26],0.5023375635121157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,41402,323,0.73 [0.63-0.85],7.195561504984723e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,41045,321,1.82 [1.29-2.58],0.0006482564761819
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,41611,321,1.21 [0.83-1.75],0.3234562413660978
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40496,312,1.42 [1.13-1.79],0.002345907032452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,35859,278,1.28 [0.86-1.90],0.2270237793233969
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,41045,321,1.13 [0.70-1.82],0.6203572536594604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,34731,268,1.01 [0.74-1.40],0.9270567755136802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,34327,269,1.02 [0.71-1.46],0.9237370722812612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,35805,276,0.73 [0.45-1.18],0.1954875012114972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,35197,269,1.06 [0.86-1.31],0.5887096262244107
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,41473,324,0.99 [0.67-1.47],0.9679090671199913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,34731,268,0.67 [0.51-0.88],0.0041146294181277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,35790,277,1.10 [1.02-1.19],0.0162935270536241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,34602,264,0.98 [0.63-1.53],0.926840408153818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",34908,268,1.08 [0.93-1.25],0.3328664558092276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,34892,262,1.00 [0.80-1.25],0.996634257056242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,35725,277,1.54 [1.32-1.80],2.9774742386319922e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,40496,312,1.28 [1.10-1.49],0.0014875201584658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,40279,316,1.01 [0.82-1.23],0.9548412118032616
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,34731,268,1.11 [0.87-1.40],0.4016838471858375
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,35912,278,1.49 [0.97-2.30],0.0686483937965406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,35790,277,1.01 [0.91-1.13],0.8014726547921973
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,40301,312,0.96 [0.89-1.04],0.3120164070435717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,34246,266,1.43 [1.18-1.72],0.0002026669493822
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,34731,268,1.12 [0.89-1.42],0.3410643072080366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",41045,321,2.72 [2.11-3.53],2.4650935616118902e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,41742,327,1.62 [1.36-1.93],9.005854706359978e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,41239,323,0.69 [0.52-0.92],0.0101524140704153
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,40279,316,1.25 [0.97-1.60],0.0882092225516133
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,35859,278,1.05 [0.86-1.29],0.6313101420583682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,40234,311,0.90 [0.72-1.11],0.3276185978406132
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,40301,312,1.15 [0.99-1.35],0.0717722503139162
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,40301,312,0.98 [0.90-1.07],0.6856682211906715
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,41549,321,1.87 [1.33-2.61],0.0002718978242127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,41045,321,1.51 [0.95-2.39],0.0837357603214181
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,40813,317,1.14 [0.80-1.63],0.4545299364954005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,34736,272,1.10 [0.92-1.32],0.3077184909096166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,40279,316,0.85 [0.72-1.01],0.0634985654197442
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,35859,278,1.02 [0.87-1.20],0.8394645141998434
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,35789,278,1.11 [0.88-1.40],0.3873825426129264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,40540,316,1.16 [0.87-1.54],0.3250502298814175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,41179,320,0.91 [0.74-1.12],0.3743031139779836
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,40937,319,1.49 [0.99-2.26],0.0581051207391846
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,41184,322,1.06 [1.00-1.12],0.0427264853587231
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,40301,312,0.97 [0.91-1.04],0.3943110252350654
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,35096,275,0.52 [0.35-0.79],0.0018195714353535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,40279,316,0.89 [0.73-1.08],0.2424343847713565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,41239,323,0.95 [0.84-1.07],0.4117890657410684
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,35805,276,1.11 [0.80-1.52],0.5365303874699728
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,35805,276,1.12 [0.97-1.30],0.1214369311653283
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,35096,275,1.22 [0.87-1.69],0.2456274620559603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,34602,264,1.26 [1.04-1.53],0.0201924493712728
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,34908,268,1.09 [0.88-1.34],0.4381607089174735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,35790,277,1.99 [1.42-2.78],5.434085366797648e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,35707,278,0.98 [0.87-1.10],0.7020969272568984
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,34825,269,0.88 [0.67-1.15],0.354284320292917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,34825,269,0.99 [0.88-1.12],0.8867463958186895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,34602,264,1.14 [0.97-1.34],0.1068670675132019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,39509,312,1.56 [1.10-2.21],0.0120582434005263
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,35025,274,1.02 [0.75-1.40],0.8784496612771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,40937,319,1.13 [0.89-1.43],0.3154120177625069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,34825,269,1.45 [1.09-1.91],0.0094426987662989
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,40502,311,1.09 [0.91-1.29],0.3495365692965305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,41146,321,1.11 [0.84-1.47],0.4566893652947834
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,34760,267,1.01 [0.74-1.38],0.9355064464051064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,40968,322,1.21 [1.02-1.43],0.0261286088758448
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",35096,275,1.04 [0.91-1.18],0.5820394960420463
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,40279,316,1.09 [0.90-1.33],0.3673265744278529
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,35697,278,1.12 [0.93-1.34],0.2228077461842899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,34995,269,1.47 [1.19-1.82],0.0003281632072526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,35859,278,1.04 [0.88-1.22],0.6551989790941959
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,41710,326,1.01 [0.83-1.23],0.9046919610236208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,35096,275,1.00 [0.84-1.19],0.9701339062284612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,35805,276,0.91 [0.79-1.05],0.1964741083638822
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,40301,312,0.96 [0.82-1.12],0.6119535930728957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,34892,262,0.86 [0.66-1.12],0.2674172455964936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,41247,323,1.21 [1.01-1.46],0.041829792257798
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,34908,268,1.19 [0.89-1.61],0.2424172412270457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,35096,275,0.90 [0.65-1.24],0.5270496482603562
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,35805,276,1.10 [0.95-1.27],0.2026483794101967
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,41603,324,1.93 [1.37-2.71],0.0001556226040464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,41195,324,1.00 [0.91-1.10],0.9807405778167568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,35707,278,0.96 [0.75-1.23],0.7405364115297413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",35864,278,1.12 [0.85-1.46],0.4262810861179493
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,41059,321,0.93 [0.69-1.26],0.6401824129565159
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,34731,268,1.02 [0.85-1.21],0.8536181488947203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39988,302,0.95 [0.84-1.08],0.4220504630422333
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,35096,275,1.00 [0.72-1.38],0.9959995719473732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,41174,323,1.01 [0.91-1.13],0.8305861123814717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,41045,321,1.04 [0.97-1.11],0.3201139152586876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,41611,321,0.79 [0.56-1.10],0.1625285995893696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,40937,319,0.83 [0.69-0.99],0.0373325236848777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,35697,278,0.84 [0.67-1.06],0.1396744737696665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,35707,278,1.21 [0.98-1.50],0.0733938563165689
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,35885,280,1.11 [0.88-1.41],0.3901897889799558
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,35707,278,1.08 [0.92-1.28],0.3468716071120972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,40279,316,1.33 [1.01-1.75],0.0422179047823235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,40135,319,1.09 [0.77-1.55],0.6285630763030287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,34760,267,0.95 [0.77-1.17],0.6097837044330713
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,35805,276,1.00 [0.72-1.38],0.9806871336580104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,35707,278,1.19 [0.99-1.43],0.0601468465311681
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,40502,311,1.15 [0.99-1.34],0.0733775014210375
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,35697,278,1.02 [0.83-1.25],0.8261772953041121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,41239,323,0.99 [0.92-1.07],0.7622680939883162
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,35859,278,1.10 [0.92-1.32],0.2999029942254321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",35805,276,0.86 [0.64-1.14],0.2915729291925282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",34760,267,1.00 [0.81-1.24],0.9719776669741188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,40502,311,1.01 [0.82-1.23],0.956454490862967
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,41047,319,2.98 [2.06-4.30],6.162154940907629e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,34908,268,0.88 [0.71-1.09],0.2517100852165386
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",41045,321,1.32 [1.14-1.53],0.0002829866021895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,34409,264,1.08 [0.94-1.24],0.3009573102456766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,40301,312,1.01 [0.90-1.14],0.8179128755222217
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,35747,279,0.60 [0.38-0.95],0.0301931785054152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",35681,279,1.63 [0.98-2.73],0.061193321914072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,41174,322,0.95 [0.85-1.07],0.4380532803757034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,40301,312,0.94 [0.82-1.07],0.3497515879788785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,34731,268,0.99 [0.84-1.16],0.8697131434305229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,40029,315,1.01 [0.88-1.17],0.8472875616884955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,35790,277,1.04 [0.99-1.09],0.1397752133793778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,35197,269,0.98 [0.83-1.16],0.7971308140748178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,34892,262,1.06 [0.92-1.23],0.4303529550540655
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,41036,322,1.32 [0.99-1.77],0.0580624467663667
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,35197,269,1.02 [0.88-1.17],0.8072952358068191
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,34731,268,1.04 [0.78-1.40],0.7690511303035719
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,41425,324,0.95 [0.80-1.11],0.5017531862893403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",40502,311,0.97 [0.87-1.09],0.6432763637032248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,41710,326,2.24 [1.81-2.77],1.4200703027499985e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,41195,324,0.86 [0.73-1.01],0.0657923353422068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,40502,311,1.24 [1.12-1.38],2.739880514431631e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,34602,264,0.98 [0.77-1.24],0.8462161890581869
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",34731,268,1.06 [0.90-1.24],0.5130048518656188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",41490,321,1.04 [0.91-1.19],0.5582602388311405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,41611,321,1.00 [0.92-1.08],0.995311851027712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",41247,323,1.01 [0.89-1.14],0.9130620259455338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,41552,321,1.15 [0.98-1.34],0.0845211848223892
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,41247,323,1.90 [1.46-2.46],1.3770377248662275e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,41490,321,0.99 [0.86-1.13],0.8700647048354025
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,41611,321,1.02 [0.87-1.20],0.7698120949156662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,35859,278,0.94 [0.84-1.04],0.2412441581000227
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,34731,268,1.14 [0.96-1.35],0.134049703244667
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,41710,326,1.03 [0.86-1.23],0.762787941086167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,34825,269,1.18 [1.01-1.38],0.040497183372391
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,34760,267,0.98 [0.81-1.18],0.8188884477873563
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,35707,278,1.25 [0.97-1.60],0.0839666084670172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,41547,321,1.07 [0.97-1.19],0.1775951580826634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,35790,277,1.25 [1.06-1.47],0.00861364796191
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,40502,311,1.00 [0.83-1.20],0.9931495143792504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,35096,275,1.39 [0.90-2.14],0.1352076641584964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,35790,277,1.10 [0.84-1.44],0.5046339454807409
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,35859,278,1.22 [0.78-1.90],0.3775865693775179
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,41195,324,1.03 [0.91-1.17],0.6074032650575215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,41710,326,1.39 [1.06-1.84],0.0187184765650199
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,35548,276,0.63 [0.48-0.83],0.0007416172090896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,40301,312,1.00 [0.88-1.14],0.9942526841676184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,35790,277,1.10 [0.95-1.27],0.2201224392940232
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,34825,269,1.11 [0.94-1.30],0.2225912904460503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,34731,268,1.02 [0.72-1.44],0.91069547042423
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,35718,275,1.49 [1.26-1.76],2.056098032756893e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,35805,276,1.07 [0.83-1.38],0.6091784097351455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,40502,311,0.99 [0.69-1.43],0.968563228026892
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",35805,276,1.65 [1.15-2.36],0.0059282263597748
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",41067,324,1.52 [1.18-1.96],0.0013871512282878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",41195,324,2.65 [2.01-3.50],3.845506458239847e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,41611,321,1.06 [0.85-1.33],0.6088286141509789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,35030,275,1.15 [0.93-1.41],0.1881775097595825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",34908,268,1.18 [0.94-1.48],0.1567025789706729
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",34731,268,1.05 [0.81-1.37],0.6952253033794646
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,34536,264,1.13 [0.90-1.41],0.2964733633798917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,40791,321,1.09 [0.89-1.34],0.4107517446675319
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,40279,316,1.29 [1.08-1.55],0.0062822038181424
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,34892,262,1.10 [0.95-1.27],0.2101325032500701
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,40734,318,1.49 [1.21-1.83],0.0001450060539152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,40368,307,0.99 [0.87-1.13],0.8560549076888251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,35805,276,1.39 [1.16-1.68],0.0004661412235817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,41710,326,1.05 [0.92-1.21],0.4370377196923323
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,40301,312,0.71 [0.54-0.93],0.0138771369371253
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,35389,274,1.11 [0.98-1.25],0.1116709343915346
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,35132,269,1.02 [0.91-1.15],0.6742580478588803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,34908,268,1.32 [0.98-1.79],0.0699693403473408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,35723,274,0.97 [0.67-1.40],0.8715120982716813
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,34908,268,1.09 [0.95-1.24],0.214135478872297
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,41045,321,1.14 [0.88-1.48],0.3337973396920648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,41611,321,1.64 [1.33-2.03],4.74063316275693e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,34825,269,1.11 [0.79-1.57],0.5359900727702673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,34908,268,1.09 [0.96-1.23],0.1739441186817731
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,41195,324,1.07 [0.83-1.37],0.59522479345763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,35790,277,1.01 [0.84-1.21],0.9574898180837512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,34731,268,1.01 [0.79-1.28],0.9618118549338132
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,34908,268,1.33 [1.06-1.69],0.0154713820014083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,40092,314,1.01 [0.87-1.17],0.8839035898751715
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,41334,323,0.99 [0.86-1.13],0.8365083303975994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,35697,278,1.38 [1.05-1.83],0.022282642979303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,40579,318,0.91 [0.79-1.05],0.207096876684078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,41611,321,1.42 [1.12-1.82],0.0043308868931743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40927,317,1.24 [0.85-1.81],0.2705102412659999
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,34760,267,1.12 [0.98-1.28],0.0945796251395058
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,34760,267,1.13 [0.89-1.46],0.3182810904161904
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",41351,323,1.02 [0.87-1.20],0.7933425789675692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,41001,323,0.70 [0.45-1.08],0.1088161080108525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,41742,327,1.60 [1.04-2.46],0.0331804527972082
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,40496,312,0.96 [0.84-1.09],0.5158219082592671
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,41064,320,2.24 [1.63-3.07],6.497031988204041e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,41742,327,1.87 [1.37-2.54],8.493826842402974e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,41742,327,5.83 [4.27-7.94],7.459818901403596e-29
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,41195,324,0.88 [0.73-1.05],0.1603392986888754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,41239,323,1.07 [0.86-1.33],0.5284005999104482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,41045,321,1.38 [0.82-2.31],0.22515142606276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,35197,269,0.98 [0.75-1.28],0.874411084647327
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,40279,316,1.11 [0.90-1.35],0.3271273019206034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",34908,268,1.28 [1.09-1.51],0.0033415502316433
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,41710,326,1.95 [0.63-6.03],0.2489849002927369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,41611,321,0.94 [0.76-1.16],0.5793510738601948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,34852,266,2.34 [1.84-2.98],4.812666044264522e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,35197,269,1.03 [0.83-1.29],0.7731476600542335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,35197,269,1.13 [0.84-1.52],0.4199530930726521
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,35707,278,1.69 [1.16-2.46],0.0063643995912455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,40496,312,1.10 [1.01-1.21],0.0333646945548278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,41402,323,2.44 [1.66-3.59],5.475441881384064e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,40937,319,0.86 [0.71-1.05],0.1327361308576462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,40279,316,1.55 [1.28-1.88],6.775388000481081e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,34760,267,1.15 [0.98-1.35],0.081561814412766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,41195,324,1.96 [1.67-2.30],8.679189386375831e-17
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,34731,268,1.02 [0.74-1.40],0.9057587614092046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,34892,262,1.00 [0.76-1.31],0.9868965986419584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,35805,276,1.07 [0.89-1.29],0.4750372107010081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,34760,267,1.08 [0.86-1.35],0.533465578422929
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,35864,278,0.49 [0.34-0.73],0.0003484012120844
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,41045,321,1.29 [0.84-1.99],0.2471537482799773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,34731,268,1.04 [0.82-1.34],0.7346449768217698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,41247,323,1.08 [0.71-1.65],0.7198816492006617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,41678,327,1.07 [0.99-1.16],0.1091239514510818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,41673,327,1.48 [1.26-1.74],1.608064806332506e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,41390,323,0.86 [0.63-1.18],0.3603491139197731
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,40726,320,1.54 [1.25-1.90],4.374454593226372e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,41056,319,1.21 [0.88-1.69],0.2453192576478549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,41742,327,1.47 [1.10-1.97],0.0090281466972529
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,41239,323,0.97 [0.73-1.31],0.8646444579689696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,34825,269,1.10 [0.96-1.26],0.170281853890895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,34731,268,0.97 [0.79-1.20],0.8071376847578184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,35850,277,1.34 [0.96-1.87],0.0891450619956333
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,34602,264,1.07 [0.95-1.20],0.241897926241405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,34908,268,0.81 [0.59-1.12],0.1991952524122612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,41045,321,1.57 [1.21-2.04],0.0006316635040878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,41239,323,1.37 [1.00-1.87],0.0514851649580835
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,35859,278,0.80 [0.69-0.92],0.0017219534798108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,41195,324,1.01 [0.91-1.12],0.8670393128412002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,40301,312,1.12 [1.02-1.23],0.0198327738346382
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,40496,312,1.46 [1.35-1.57],2.6820494882990924e-23
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,40496,312,1.20 [1.04-1.37],0.0103744760943131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,41402,323,1.90 [1.44-2.51],5.954656743848205e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,40496,312,1.01 [0.86-1.18],0.9131434880495892
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,41045,321,1.77 [1.59-1.98],1.7583393842782273e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,41710,326,2.29 [1.93-2.71],1.414346047543001e-21
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,40496,312,2.30 [1.84-2.88],2.221749292746697e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,34825,269,1.15 [0.87-1.51],0.3279704042132528
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,40496,312,1.15 [0.97-1.36],0.0978602258032932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,40708,318,0.76 [0.49-1.18],0.2186428575752481
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,34760,267,0.82 [0.55-1.23],0.3344440976037608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,41195,324,1.08 [0.80-1.45],0.6257324100301453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,40496,312,2.14 [1.62-2.84],1.0549566305428057e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,41710,326,1.42 [1.17-1.73],0.0004947590619629
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,40432,312,1.12 [0.90-1.39],0.3264332345262131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,40496,312,1.11 [0.97-1.27],0.1268832340656243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,40496,312,1.15 [0.89-1.50],0.2923223820732676
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,40496,312,1.04 [0.92-1.18],0.5137466073559955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,41247,323,1.08 [0.86-1.34],0.5152501768091645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,40679,324,1.45 [1.21-1.74],6.733984026172455e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,41062,320,1.76 [1.46-2.12],2.071642424093057e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,41390,323,2.71 [2.07-3.53],2.2256322281513172e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,41710,326,1.74 [1.30-2.32],0.000169800779234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,40677,318,0.99 [0.93-1.05],0.6770610617110397
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,40208,317,1.22 [1.07-1.39],0.0028764372664798
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,40496,312,1.09 [0.93-1.27],0.2816162848537556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,40306,308,1.17 [0.99-1.38],0.0577752577055353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,41179,320,2.24 [1.50-3.34],7.258367463241187e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,41143,321,0.57 [0.35-0.92],0.0229462961917181
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,41247,323,1.04 [0.84-1.30],0.6990008657286052
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,41613,326,1.16 [0.93-1.43],0.1820873957443822
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,40496,312,1.14 [0.87-1.48],0.3361348972035113
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,41137,322,1.18 [1.00-1.39],0.0522365752193758
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,40496,312,1.13 [0.82-1.56],0.4477951824625176
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,40496,312,1.17 [1.00-1.39],0.0566856253170428
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,40496,312,1.01 [0.81-1.26],0.9261893607159652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,34825,269,1.15 [0.88-1.51],0.3043910882451231
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,34825,269,0.92 [0.74-1.16],0.4897683549129263
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,35697,278,1.16 [0.99-1.36],0.0697195660303815
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,40496,312,1.13 [0.92-1.39],0.2431740893700384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,40496,312,1.03 [0.85-1.26],0.7477199769292531
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,34474,264,0.72 [0.51-1.01],0.0598687699763349
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,40952,322,3.50 [2.96-4.15],4.046417405578913e-48
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,40496,312,1.24 [0.99-1.55],0.0566235895401879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,35697,278,1.49 [1.21-1.84],0.0001492239188902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,34602,264,1.05 [0.86-1.28],0.6173229986731763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,34825,269,0.88 [0.70-1.10],0.2639326410569959
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,34692,267,0.91 [0.67-1.23],0.5210722935480989
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,41195,324,1.49 [1.21-1.83],0.0001362323728534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,40496,312,1.28 [0.99-1.65],0.0565523301735105
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,40219,316,1.26 [0.94-1.67],0.1166468066389154
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,34825,269,0.94 [0.76-1.17],0.5679660028549256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,34697,268,1.06 [0.90-1.26],0.4562816937167903
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,40496,312,1.66 [1.24-2.22],0.0007147930007039
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,40496,312,0.98 [0.88-1.10],0.7782056387289432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,41195,324,2.11 [1.68-2.65],1.6289493785459027e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,40496,312,1.03 [0.97-1.11],0.3247913733290675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,41195,324,1.14 [0.95-1.35],0.1528022105703647
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,41045,321,1.29 [1.17-1.43],3.825160811710193e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,40995,320,1.08 [0.81-1.44],0.5976555606600682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,41239,323,1.06 [0.60-1.87],0.8345913904409907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,41195,324,0.98 [0.84-1.14],0.7924711032995302
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,41247,323,0.95 [0.79-1.15],0.6019115051809397
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,35197,269,1.06 [0.87-1.29],0.5696111215322401
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,40221,314,1.19 [1.02-1.40],0.0322122543525388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,35697,278,1.56 [1.29-1.88],4.335470102095523e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,40937,319,1.04 [0.88-1.22],0.6602359995093605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,35790,277,1.16 [0.94-1.42],0.1670855063213008
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,34760,267,0.93 [0.62-1.39],0.7326034253353851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,40203,316,1.22 [1.01-1.47],0.035983401549648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,35096,275,1.32 [1.06-1.64],0.0118801996959254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,41247,323,0.96 [0.76-1.22],0.7624378479213537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,41045,321,1.19 [0.99-1.42],0.0614090832866153
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",34908,268,1.21 [0.99-1.48],0.0667587356699469
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",35805,276,0.97 [0.74-1.28],0.8375610312361199
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",41045,321,1.00 [0.90-1.11],0.985663058417492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,35790,277,0.81 [0.70-0.93],0.0029158900105794
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,35697,278,0.94 [0.74-1.20],0.6350837214492437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,35707,278,1.06 [0.94-1.19],0.3502659990342043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,34825,269,1.12 [0.56-2.25],0.7554824610953081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,40867,318,1.05 [0.94-1.17],0.4208535598205348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,41045,321,1.11 [0.93-1.32],0.2565883371878357
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40502,311,1.12 [1.01-1.25],0.0382969444310212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,40496,312,0.99 [0.86-1.15],0.9393722105027744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,41195,324,1.01 [0.92-1.11],0.8981155524470897
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39695,314,0.89 [0.68-1.16],0.3808265207031071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,41195,324,0.82 [0.64-1.06],0.1265589933153009
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,35864,278,1.06 [0.82-1.37],0.66267897738736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,35441,278,0.98 [0.87-1.10],0.7616501001596967
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,41195,324,0.65 [0.49-0.86],0.0029586979514718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,35096,275,0.65 [0.46-0.90],0.0110370636652251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,41247,323,1.45 [0.98-2.15],0.061141215540937
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,41195,324,0.88 [0.72-1.07],0.1920576488699448
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,34825,269,1.65 [1.24-2.19],0.0005638781748375
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,41247,323,0.83 [0.61-1.14],0.2467543468556836
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,41611,321,0.45 [0.25-0.81],0.0073975633145754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,35197,269,1.20 [0.99-1.46],0.0585095595105926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,41196,322,0.77 [0.48-1.23],0.2657428585463203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,40301,312,1.09 [0.85-1.39],0.4944070393515353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,40502,311,1.05 [0.95-1.15],0.3329197664832093
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,41000,321,1.75 [1.26-2.44],0.0007972721225502
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,41351,323,0.78 [0.59-1.02],0.0698552430812112
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,40496,312,0.85 [0.61-1.19],0.3475837300247562
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,41611,321,1.47 [1.21-1.80],0.000124284722384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,35864,278,1.50 [1.13-2.01],0.0058160779398949
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,35912,278,1.03 [0.56-1.89],0.9250857384662424
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,41390,323,1.46 [1.12-1.90],0.0048317181349376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,35912,278,1.23 [0.80-1.90],0.3491647209276169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,35697,278,1.13 [0.89-1.43],0.3328880187328989
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,41195,324,1.45 [1.24-1.69],3.7408550915267697e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,34731,268,1.11 [0.94-1.32],0.2270651733308804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",34908,268,1.15 [0.99-1.34],0.0754106302596853
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",34760,267,0.94 [0.72-1.23],0.6561021175537989
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",40279,316,1.13 [0.94-1.37],0.1862744200681011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,34602,264,1.04 [0.82-1.33],0.755662448189079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,41603,324,1.36 [0.94-1.96],0.1025447344843517
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,35096,275,1.14 [0.91-1.43],0.2416524989858586
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,40496,312,1.63 [1.40-1.89],2.1740420159987558e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,34602,264,1.02 [0.83-1.25],0.8828998591543172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,35707,278,1.02 [0.89-1.16],0.8241892243697857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,40496,312,1.26 [1.07-1.47],0.0046473374447698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,41045,321,1.32 [1.04-1.66],0.0195951772356271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,35707,278,0.98 [0.88-1.09],0.7204932495736867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,34760,267,0.94 [0.75-1.18],0.6079921194763804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,34892,262,1.06 [0.91-1.22],0.4481916340461918
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,40279,316,1.02 [0.84-1.24],0.871285216149833
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,35105,268,1.62 [1.35-1.95],1.6355174766166962e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,34825,269,1.10 [0.98-1.23],0.1081485708360964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,41351,323,0.76 [0.52-1.11],0.1526213733332652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,40279,316,1.28 [0.97-1.69],0.0771699405534558
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,34602,264,1.08 [0.92-1.26],0.3567689162186404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,34908,268,1.21 [1.00-1.46],0.044885005518779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,35790,277,1.06 [0.73-1.53],0.7606429521810967
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,35197,269,1.04 [0.88-1.23],0.6210571599229513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,35197,269,0.87 [0.57-1.33],0.5309421887175729
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,35697,278,1.15 [0.96-1.37],0.1217989658808864
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,34731,268,1.31 [1.00-1.72],0.049131744576174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,34760,267,1.11 [0.96-1.27],0.1625702409703769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,34731,268,0.98 [0.89-1.08],0.7229419487760954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,41045,321,1.03 [0.91-1.16],0.6830035916192483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,35697,278,1.11 [0.98-1.27],0.1048467296459027
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,40301,312,1.14 [1.00-1.29],0.0437961864421783
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,35707,278,0.95 [0.89-1.02],0.1563794476026883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,40301,312,0.96 [0.89-1.04],0.3563592451570621
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,34602,264,1.01 [0.88-1.16],0.9339013275488208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,34760,267,1.07 [0.89-1.29],0.4721574809672689
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,40279,316,1.50 [1.20-1.86],0.0003369384675101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,41330,322,0.62 [0.45-0.87],0.0052718791360048
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,41239,323,0.83 [0.64-1.08],0.1591136306249533
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,40279,316,1.05 [0.91-1.20],0.5067327213928572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,34760,267,1.08 [0.82-1.43],0.5880351994644031
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,35805,276,0.86 [0.66-1.11],0.2348090856157539
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,40822,318,0.95 [0.88-1.03],0.230252185146139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,41226,323,0.99 [0.77-1.26],0.9217386850762987
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,40944,323,1.41 [1.08-1.84],0.0128511648252432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,40301,312,1.06 [0.98-1.14],0.1234245331124131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,40304,314,1.27 [1.02-1.59],0.0325642860057339
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,41611,321,1.03 [0.83-1.27],0.780368632685951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,35641,278,1.20 [0.96-1.49],0.1116198254427079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,35864,278,0.98 [0.86-1.11],0.7461468959402469
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,41611,321,1.20 [1.03-1.39],0.0166945594253202
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,41286,322,0.95 [0.69-1.31],0.7596190232055907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,34187,266,0.87 [0.63-1.19],0.3728500338687363
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,39850,314,1.08 [0.82-1.43],0.5714635443963643
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,35191,270,0.69 [0.43-1.09],0.1134394269048906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,41710,326,2.22 [1.74-2.82],9.713940285989663e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,34760,267,1.08 [0.90-1.30],0.4170953011740722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,41710,326,1.67 [1.36-2.05],1.1791120635926671e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,34825,269,1.15 [0.92-1.45],0.2269896698749191
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,35790,277,1.79 [1.48-2.18],2.692131624671156e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",38996,306,1.06 [0.75-1.50],0.7389274081195506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",34731,268,1.09 [0.81-1.47],0.5493347721714174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",41045,321,1.14 [1.01-1.28],0.0275555768415779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",41131,324,1.29 [1.12-1.47],0.0003244056481384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",40279,316,1.10 [0.90-1.33],0.3586584425665874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",34731,268,1.04 [0.77-1.41],0.7793094875609622
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",34760,267,0.99 [0.85-1.16],0.927377770148488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,41169,323,1.12 [0.95-1.33],0.1864721184242176
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,41710,326,1.23 [0.99-1.51],0.0597673918242138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,41351,323,1.31 [0.94-1.84],0.1140977953955264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,35859,278,0.99 [0.87-1.13],0.918670061376828
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,35626,278,1.00 [0.79-1.27],0.9781725003966814
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,41239,323,1.03 [0.88-1.19],0.7270774481770961
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,41045,321,2.15 [1.82-2.53],8.533666918952097e-20
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,41202,322,2.02 [1.66-2.47],3.937530987258661e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40937,319,1.28 [1.16-1.42],1.9916569023018263e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,34731,268,1.08 [0.88-1.33],0.4505272309704825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,41402,323,0.94 [0.70-1.27],0.693954581150142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,34908,268,1.17 [0.80-1.73],0.4172667644093324
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,34876,269,0.82 [0.50-1.32],0.4053045475977954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,39980,304,0.78 [0.47-1.29],0.330074372141053
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,41636,325,1.42 [1.18-1.71],0.000190265217838
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,35697,278,1.34 [1.06-1.70],0.0161336760351101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,40496,312,0.99 [0.80-1.22],0.9429540912274204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,35697,278,0.96 [0.80-1.16],0.6749331445680167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,41710,326,0.98 [0.86-1.11],0.741877737330229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,41045,321,0.98 [0.91-1.06],0.6726010233932791
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,34825,269,0.95 [0.82-1.09],0.4556193098996773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,40861,319,1.75 [1.34-2.28],4.083242955963483e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,41390,323,1.17 [0.99-1.39],0.0591918755137079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,41603,324,1.12 [0.98-1.28],0.0925271000166081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,35885,280,0.88 [0.53-1.47],0.6367470317338437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,35805,276,1.13 [0.95-1.34],0.1557685730396331
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,39999,310,1.35 [1.06-1.73],0.0156751576326884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,35864,278,1.33 [1.07-1.66],0.0114759764919804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,41348,324,0.99 [0.82-1.19],0.8802457894689153
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,35805,276,0.96 [0.85-1.08],0.4931402260559188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,35859,278,1.09 [0.92-1.30],0.3245889544484591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,41549,321,0.89 [0.73-1.08],0.2303916225574469
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,33890,267,1.03 [0.87-1.22],0.7156934377025466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,34760,267,0.99 [0.84-1.17],0.9448677070766986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,35805,276,1.07 [0.76-1.49],0.7092269109677095
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEP,Leptin,41239,323,0.91 [0.79-1.06],0.2156949157154506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,41239,323,0.95 [0.69-1.31],0.7581634984143577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,35805,276,1.34 [1.11-1.63],0.0028349485927504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,41239,323,1.38 [1.04-1.82],0.0238164454011465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,41348,324,1.31 [0.94-1.81],0.1064146924547924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,35912,278,1.23 [0.86-1.74],0.2528185869557172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,41202,322,1.29 [1.09-1.54],0.0032671762813203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,41171,321,1.19 [0.95-1.49],0.1394228710702597
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,41603,324,1.11 [0.94-1.30],0.2102314322022848
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,41214,321,2.86 [2.17-3.77],8.226044558114037e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,41402,323,1.35 [1.04-1.77],0.0263125867708436
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,40301,312,1.06 [0.95-1.18],0.3255213412714254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,41264,323,1.01 [0.86-1.19],0.8689587457374767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,40279,316,1.21 [1.03-1.42],0.0233378201463635
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,41195,324,1.61 [1.09-2.39],0.0180547454593445
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,41247,323,1.69 [1.27-2.26],0.000362066303408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,35864,278,1.08 [0.98-1.19],0.1253958321709224
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,34731,268,1.32 [1.10-1.59],0.0028269805340987
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,41184,322,2.02 [1.50-2.73],4.683059484821908e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,35859,278,1.04 [0.89-1.22],0.5999300149295015
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,41742,327,2.73 [1.92-3.89],2.283259605436943e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,41544,326,1.73 [1.29-2.33],0.0002560732837027
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40496,312,2.14 [1.73-2.63],1.2421880176133424e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,41742,327,1.04 [0.90-1.19],0.6028793168744127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,34908,268,0.98 [0.81-1.18],0.7971903047043079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,35637,278,1.21 [1.03-1.42],0.0227497433230206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,35790,277,2.95 [2.23-3.90],2.9673418955159585e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,35805,276,1.05 [0.76-1.46],0.7534840424108091
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,34760,267,1.02 [0.85-1.23],0.8367208141438696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",34908,268,1.10 [0.97-1.26],0.1499346152009443
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),35063,273,1.04 [0.97-1.11],0.2607646631826834
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,41045,321,1.23 [1.03-1.47],0.019405920127875
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,41239,323,0.97 [0.79-1.19],0.7414632975823761
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,39889,312,1.04 [0.88-1.22],0.6848592312326607
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,34731,268,1.04 [0.87-1.25],0.6472410585476357
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,34731,268,1.13 [0.96-1.33],0.1537405866855372
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,34892,262,0.99 [0.77-1.28],0.939893305014314
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,35912,278,2.92 [2.00-4.27],2.9061699342741723e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,41490,321,2.26 [1.73-2.95],1.6680442220688363e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,34702,269,1.14 [0.77-1.70],0.5067664756660069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,41045,321,1.28 [0.89-1.85],0.1786930688479257
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,41239,323,1.28 [0.98-1.67],0.0741500465125295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,34892,262,0.84 [0.59-1.18],0.3090284088610809
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,34892,262,1.10 [0.97-1.24],0.154910862069813
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,41603,324,1.08 [0.92-1.27],0.3609096326060437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,41045,321,1.51 [1.22-1.87],0.0001718746070803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,35707,278,1.41 [1.08-1.84],0.0111634449903252
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,34892,262,1.02 [0.80-1.30],0.8924636754474382
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,35859,278,1.10 [0.87-1.39],0.4169245532651596
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,35697,278,1.06 [0.84-1.34],0.6037208402712511
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,40496,312,0.74 [0.57-0.95],0.0189902677821961
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,34892,262,1.31 [1.04-1.65],0.0234121946684595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,35805,276,0.88 [0.56-1.38],0.5874067456012664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,40301,312,1.09 [0.92-1.30],0.3055306702170595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,35197,269,0.96 [0.83-1.10],0.5441058115132638
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,41195,324,1.50 [1.19-1.89],0.0005048779202236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,41195,324,2.24 [1.94-2.58],1.6071351153940014e-28
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,41611,321,1.02 [0.86-1.20],0.8551224846018408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,35697,278,1.18 [0.88-1.58],0.2666670429822025
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,41742,327,2.03 [1.51-2.73],2.6059252575048727e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,40301,312,1.27 [1.09-1.49],0.0027762043158941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,41007,321,2.14 [1.56-2.94],2.1962265018033707e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,40496,312,1.08 [0.86-1.37],0.5038817619257367
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,35697,278,1.31 [1.06-1.63],0.0134067752388525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LXN,Latexin,40747,315,0.99 [0.86-1.15],0.9066687886547168
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,41014,321,1.43 [1.12-1.82],0.0040959290671986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,41195,324,1.73 [1.33-2.26],5.181825613737072e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,40789,319,6.45 [4.89-8.53],2.429523748914641e-39
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,40937,319,1.40 [1.08-1.80],0.0107582063112892
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,40301,312,1.12 [0.95-1.31],0.1910630308005149
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,41045,321,0.97 [0.86-1.09],0.6139117211635181
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,40279,316,1.00 [0.85-1.17],0.9817865957111434
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,41024,323,1.15 [0.86-1.53],0.3585754768070851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,40301,312,1.48 [1.30-1.68],1.409592056590183e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,34760,267,0.99 [0.89-1.11],0.9189033847078628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,34892,262,1.03 [0.92-1.15],0.5760083963208511
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,35912,278,0.71 [0.40-1.28],0.258476347027697
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,34602,264,0.67 [0.47-0.97],0.0331866518978655
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,35096,275,0.97 [0.83-1.15],0.7566856167208776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,34908,268,1.35 [1.07-1.71],0.0113433283431499
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40795,318,1.47 [1.29-1.67],1.1116032054120376e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,40301,312,1.07 [0.83-1.37],0.6043422080999066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,34892,262,1.01 [0.79-1.30],0.90810929291542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,35197,269,0.91 [0.80-1.03],0.1401346993166812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,40301,312,1.25 [1.03-1.51],0.0265345864154654
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,35859,278,1.18 [0.85-1.63],0.3282626026868618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,35697,278,0.78 [0.63-0.97],0.0264634043292587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",34908,268,2.94 [1.86-4.66],4.096542090862239e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,35859,278,0.90 [0.75-1.09],0.293320302898579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",34602,264,0.91 [0.71-1.15],0.4227554968150807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,41402,323,1.00 [0.92-1.08],0.926286372612106
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,41351,323,1.42 [0.99-2.01],0.0535418670635226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,34731,268,1.14 [0.97-1.35],0.1128024232020059
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,34760,267,0.71 [0.49-1.04],0.078967887646649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,34731,268,1.05 [0.89-1.24],0.5744002653115623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,35790,277,1.15 [0.90-1.46],0.2605097706556699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,35707,278,1.12 [0.94-1.34],0.214894483077508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,41195,324,0.95 [0.87-1.05],0.3562797442289953
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,40301,312,1.06 [0.95-1.17],0.2880219375997207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40861,319,1.04 [0.95-1.13],0.4253370807921613
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,34602,264,1.29 [1.02-1.61],0.0303358248576117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,41195,324,1.12 [0.89-1.41],0.3338796644911737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,35197,269,1.06 [0.90-1.24],0.4901501408774241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,34602,264,1.05 [0.98-1.13],0.1715689810113932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,40279,316,1.04 [0.86-1.26],0.6795572337324999
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,41239,323,3.06 [2.12-4.43],2.5903892802076086e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",35025,274,1.04 [0.91-1.20],0.5443295910245995
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,40861,319,1.12 [0.73-1.71],0.6089929866048884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,41274,322,1.83 [1.31-2.54],0.0003621486871301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,40867,318,1.12 [0.82-1.52],0.4740024362716681
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,40301,312,1.06 [0.95-1.18],0.2907970276677888
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAX,Protein max,40279,316,1.03 [0.94-1.13],0.523735961143674
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,41742,327,1.22 [1.02-1.44],0.0268979543452322
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,35406,273,1.07 [0.96-1.19],0.2060617071821902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,41390,323,0.83 [0.62-1.12],0.2255187751243567
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",35805,276,1.16 [0.90-1.49],0.2533909364938693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,34825,269,1.00 [0.88-1.14],0.9775606641897924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,41043,321,1.10 [0.88-1.37],0.4134878742413223
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,35707,278,0.96 [0.62-1.49],0.8465970916139577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40937,319,1.14 [0.99-1.32],0.0676852398717447
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",35681,279,1.17 [0.89-1.55],0.2526010783193467
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDK,Midkine,41229,323,1.20 [1.00-1.42],0.0457420778457185
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,34892,262,1.05 [0.71-1.54],0.8148734721527134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",34908,268,1.09 [0.96-1.24],0.1639831571091183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,40301,312,1.05 [0.92-1.20],0.472297131679919
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,34731,268,0.92 [0.71-1.19],0.5250863644202155
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,41202,322,0.93 [0.72-1.20],0.582258428256372
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,34731,268,1.06 [0.76-1.49],0.7316462697563393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,41613,326,0.93 [0.56-1.52],0.7621745736596064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,35859,278,1.09 [0.74-1.61],0.6483793212497122
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,35096,275,0.53 [0.32-0.87],0.0126322848323028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,35707,278,0.88 [0.75-1.04],0.1361260414091936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,41239,323,0.96 [0.88-1.04],0.2855277022842242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,41202,322,0.89 [0.61-1.32],0.5735827571556076
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,41710,326,1.73 [1.19-2.53],0.004395621731097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,41247,323,1.00 [0.92-1.09],0.9748951439262896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,41341,322,0.89 [0.54-1.46],0.6474428243117935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,40279,316,1.26 [0.92-1.73],0.1456333949812069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",41195,324,1.01 [0.89-1.13],0.931998869535064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,41549,321,1.04 [0.87-1.23],0.6761544321701465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,40502,311,0.97 [0.79-1.20],0.7683909486205068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,34892,262,1.05 [0.89-1.25],0.5524821710439263
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,35096,275,0.97 [0.67-1.40],0.8666042067249373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,41742,327,0.94 [0.74-1.20],0.637354134833454
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,41247,323,1.01 [0.80-1.26],0.965145633803002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,41341,322,0.95 [0.85-1.06],0.3449031193140902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,41195,324,1.00 [0.92-1.08],0.9330006771652788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,41351,323,1.22 [0.94-1.58],0.1344674834335414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,34892,262,0.98 [0.82-1.16],0.7790328234129644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,41195,324,1.06 [0.99-1.14],0.1133151872384778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,41181,322,1.06 [0.91-1.22],0.4481127566405282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,40496,312,1.49 [1.23-1.80],3.451186506501602e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,35697,278,0.98 [0.88-1.09],0.7625895716247573
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,35790,277,1.03 [0.91-1.16],0.6695285194404125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,40937,319,1.03 [0.93-1.14],0.576409622242575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,34825,269,1.36 [1.09-1.70],0.0058648880196536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,34602,264,0.99 [0.83-1.19],0.9439420794834394
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,41195,324,1.07 [0.96-1.20],0.200154514345958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,41045,321,0.97 [0.85-1.09],0.5865025712501752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,39751,311,1.14 [1.01-1.27],0.0266482122549679
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,41146,320,1.06 [0.90-1.26],0.4930678384358126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,41301,321,1.58 [1.33-1.88],2.022132783135317e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,40279,316,1.12 [0.82-1.52],0.481251656897217
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,35859,278,1.20 [1.00-1.44],0.0550135165529584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,41247,323,1.00 [0.81-1.22],0.9756449164937762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,40437,311,1.31 [1.06-1.62],0.0138786372610658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,41531,322,1.01 [0.88-1.16],0.8827307855319767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,41185,322,1.03 [0.88-1.21],0.713016284168997
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",34731,268,0.99 [0.78-1.26],0.9360434173052752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,34892,262,1.06 [0.87-1.29],0.5555956372378493
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,35197,269,1.21 [0.96-1.53],0.099915137274254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,41174,322,1.01 [0.92-1.11],0.8485167568538299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,35096,275,1.04 [0.87-1.24],0.6662035468275536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,41611,321,0.98 [0.73-1.33],0.9206551461352755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,35790,277,1.34 [0.94-1.91],0.1113670623025155
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,35197,269,0.92 [0.68-1.25],0.607007742674101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,34602,264,1.13 [0.84-1.51],0.4232646375516412
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,34602,264,0.98 [0.84-1.14],0.7924865403452301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,40502,311,1.04 [0.91-1.19],0.526089107972546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,41045,321,1.04 [0.92-1.16],0.5473613204459342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,41341,322,1.01 [0.89-1.15],0.907525863853957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,41247,323,1.44 [1.20-1.73],9.362006333990724e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,35627,278,0.78 [0.60-1.02],0.0740650916010988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,35885,280,1.53 [1.03-2.26],0.0345110161499264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,34892,262,1.16 [0.97-1.38],0.1123453014980889
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",34731,268,1.24 [0.96-1.60],0.0953224523108859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",35805,276,0.97 [0.71-1.34],0.8614052905409157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",40279,316,1.30 [0.94-1.80],0.1125693661546941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",34536,264,1.29 [0.89-1.87],0.1744837654847342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",35805,276,1.05 [0.90-1.23],0.5134543193691941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",34825,269,0.98 [0.66-1.48],0.9357300434956136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,40984,321,1.14 [0.97-1.35],0.1208888630275453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,34892,262,1.23 [0.92-1.64],0.1630431421858708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,41134,324,1.01 [0.88-1.16],0.8892559477133377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,41603,324,1.17 [0.94-1.45],0.1588094622895841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,41351,323,1.00 [0.87-1.14],0.9592745683823358
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,35340,274,0.85 [0.75-0.97],0.0170302128175037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,40502,311,0.88 [0.73-1.07],0.190150499228929
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,34825,269,1.11 [0.98-1.26],0.0951666203918755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",35790,277,1.51 [1.03-2.20],0.0343934343283769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,35197,269,1.02 [0.92-1.14],0.6628361623928409
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",35707,278,1.00 [0.88-1.14],0.957260552240624
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,40502,311,1.19 [0.90-1.56],0.2203965355810724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,34731,268,0.83 [0.68-1.03],0.0879937921866284
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,35707,278,1.03 [0.93-1.14],0.5978614714577735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,35697,278,1.06 [0.95-1.19],0.2897962913912054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,35197,269,1.12 [0.92-1.37],0.2516955869773526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,40279,316,1.12 [0.92-1.36],0.2706101835577463
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,41045,321,1.05 [0.99-1.11],0.0820454808968805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,35864,278,0.88 [0.77-0.99],0.0390796143370044
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,34602,264,0.90 [0.67-1.21],0.4932904323323595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,40496,312,1.09 [0.96-1.23],0.1924306402254147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,35096,275,0.84 [0.57-1.22],0.3547926299200221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",35859,278,1.21 [1.04-1.40],0.0140861953864881
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",34908,268,1.11 [0.99-1.26],0.0850791719150578
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,35805,276,1.00 [0.84-1.19],0.9810888971111348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,35859,278,1.02 [0.91-1.14],0.7336231090292411
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,34731,268,0.86 [0.65-1.14],0.2984195917716837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,34602,264,0.82 [0.61-1.11],0.1950263047545193
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,35864,278,0.95 [0.86-1.05],0.3148633947414853
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",34731,268,0.95 [0.70-1.29],0.7442423506776128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,34908,268,1.24 [1.07-1.45],0.0055235884296289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,34908,268,1.20 [0.99-1.47],0.0667920986772795
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,34892,262,1.08 [0.96-1.22],0.1780379860381883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",34892,262,1.03 [0.81-1.31],0.8017855900388924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,35805,276,1.11 [0.84-1.49],0.4591837364360793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,40496,312,1.00 [0.86-1.17],0.967416820587402
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,41247,323,0.82 [0.66-1.01],0.066354440619165
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,34760,267,1.12 [0.89-1.40],0.3312797940235907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,34731,268,1.19 [0.97-1.47],0.1029310586643157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,35096,275,1.10 [0.98-1.25],0.115121957189335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,41335,323,1.38 [1.15-1.66],0.0005862112249954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,40301,312,1.06 [0.88-1.28],0.5608199826069296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,34731,268,1.03 [0.82-1.30],0.796726511621985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,34892,262,1.01 [0.92-1.12],0.8319929310751033
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,40750,317,1.18 [1.00-1.39],0.0453597991552963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,35697,278,1.11 [0.90-1.35],0.3259558752012645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,41239,323,1.05 [0.88-1.24],0.5847680935843904
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,34759,269,1.22 [1.03-1.43],0.0190328954452557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,34842,267,1.30 [1.06-1.59],0.0109860986740762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,35096,275,1.03 [0.60-1.77],0.908103985288672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,40301,312,1.19 [1.02-1.39],0.0253594763386966
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,35641,278,1.02 [0.77-1.34],0.9043958089661296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,35790,277,1.24 [0.90-1.70],0.1899408204414082
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",35805,276,1.05 [0.82-1.33],0.7205883181916023
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,41351,323,1.73 [1.21-2.48],0.002866665772782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,40496,312,1.20 [1.02-1.40],0.0236913349036277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,41390,323,0.71 [0.51-0.98],0.0397958588308755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,41247,323,0.74 [0.51-1.07],0.1060382394837767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,41603,324,1.05 [0.81-1.36],0.736624309485062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,41128,324,1.05 [0.94-1.17],0.3792839675361711
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,41402,323,0.98 [0.89-1.07],0.6639300509385047
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,40496,312,1.22 [1.06-1.42],0.0074424432825159
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,41135,322,1.54 [1.18-2.00],0.0013867768345916
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,35707,278,1.79 [1.30-2.47],0.0003349367398243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,41611,321,1.58 [1.12-2.23],0.0090167694524576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,40279,316,1.18 [1.05-1.33],0.0067310865311875
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,35697,278,1.01 [0.84-1.21],0.8981351365685247
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,34762,269,1.18 [0.85-1.63],0.3224175682071185
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,35707,278,0.95 [0.84-1.08],0.4604425359866799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",40301,312,1.12 [1.01-1.26],0.0389692622014547
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,34731,268,0.92 [0.66-1.28],0.6186741791899806
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,34731,268,1.04 [0.88-1.24],0.629244496479793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,34825,269,1.10 [0.77-1.55],0.6064064415244694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,41184,322,2.07 [1.52-2.81],3.30658730860094e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,41351,323,1.51 [1.12-2.03],0.0066858452720198
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,34825,269,0.84 [0.67-1.06],0.1424594096885051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,34825,269,1.45 [1.10-1.90],0.0073899993507312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,40147,315,1.30 [1.05-1.62],0.0161327522537864
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,35197,269,0.90 [0.76-1.07],0.2274381406568513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,41351,323,0.79 [0.62-0.99],0.0450487982382991
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,41402,323,1.34 [0.96-1.88],0.0864950607450911
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,35697,278,0.98 [0.88-1.09],0.6855249224981343
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,35805,276,0.98 [0.59-1.64],0.9452991110741982
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,35885,280,0.86 [0.72-1.02],0.078980700566496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,41710,326,1.63 [1.16-2.29],0.0044321756489105
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,34825,269,1.06 [0.92-1.21],0.4157473725342255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",41195,324,0.99 [0.89-1.09],0.8084578902808279
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40496,312,0.87 [0.72-1.03],0.1114090827238342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,34908,268,1.08 [0.92-1.26],0.3513591863067169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,35805,276,0.96 [0.73-1.26],0.759257500998799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,34731,268,1.08 [0.92-1.27],0.3476894985742431
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,35197,269,0.95 [0.76-1.19],0.6720688318996482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,40301,312,1.52 [1.27-1.83],8.242532255845037e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",35707,278,1.04 [0.93-1.16],0.5299703666075261
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,34731,268,0.96 [0.81-1.15],0.6729688835632704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,34731,268,1.28 [1.00-1.63],0.0454823869882619
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,40937,319,0.90 [0.40-2.02],0.79551250819838
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,35859,278,1.51 [1.13-2.03],0.0056711923857011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,35790,277,1.47 [0.94-2.31],0.092586188592354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,34246,269,2.42 [1.65-3.55],6.585581318590386e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,41257,321,1.11 [0.86-1.43],0.4340039056827668
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,41247,323,1.04 [0.92-1.19],0.5068720365712698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,40301,312,1.16 [0.99-1.35],0.0658712982528406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,34908,268,1.09 [0.84-1.40],0.5233523509495492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,35727,275,1.07 [0.92-1.26],0.3736311097647389
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,34892,262,1.00 [0.84-1.19],0.9791102664071788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,34760,267,1.01 [0.79-1.30],0.9105190799743408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,34825,269,1.32 [0.78-2.23],0.2999199058440485
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,41274,322,0.95 [0.62-1.46],0.8246723525058752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,35560,278,1.17 [1.00-1.36],0.050034808979365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40937,319,1.15 [1.02-1.29],0.0232891089499299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,34602,264,1.02 [0.77-1.36],0.8830196004275357
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,35805,276,1.12 [0.96-1.31],0.1488484742468037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,41247,323,1.08 [0.71-1.65],0.7036480021305509
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,34731,268,0.97 [0.87-1.09],0.6043830932948584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",40279,316,1.47 [1.24-1.74],6.66276358754834e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",34731,268,0.89 [0.65-1.22],0.4704040700633936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",40279,316,2.02 [1.86-2.20],4.439624848230509e-62
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,41742,327,3.79 [2.09-6.87],1.1168300710152592e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,35864,278,1.73 [1.04-2.88],0.0353971968563583
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,41742,327,1.34 [1.00-1.78],0.0477216851387628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,35262,272,2.21 [1.72-2.85],8.261738059793903e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,41239,323,1.67 [1.26-2.22],0.00034530915708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,34825,269,1.34 [0.96-1.85],0.0822230211901705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,34825,269,1.00 [0.89-1.12],0.9778804037895494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,35859,278,1.20 [0.94-1.54],0.1438127461317867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,40502,311,1.09 [1.01-1.18],0.0196377069489403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,41195,324,1.47 [1.22-1.78],5.2433789831866296e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,34731,268,0.87 [0.64-1.19],0.3803160602373228
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,40301,312,1.06 [0.95-1.19],0.3059217666161634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,41247,323,0.75 [0.59-0.97],0.0284792968284565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,35864,278,0.62 [0.44-0.88],0.006931000272104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,41239,323,0.96 [0.72-1.28],0.7962993722069435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,41611,321,0.94 [0.81-1.09],0.3913752994922193
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,41239,323,2.03 [1.46-2.82],2.2826345405490794e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,35885,280,0.99 [0.87-1.12],0.8950572192977675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,35805,276,0.93 [0.66-1.30],0.6589026158786702
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,41466,323,1.41 [1.00-2.01],0.0532195066225456
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,41247,323,1.86 [1.36-2.54],9.40815450632346e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,40496,312,1.18 [0.99-1.41],0.072323418302753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,34892,262,0.96 [0.68-1.35],0.7971876134644743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,41603,324,0.98 [0.85-1.14],0.8316599732191261
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",35859,278,1.04 [0.89-1.22],0.6029602557345215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,35790,277,1.52 [1.16-2.00],0.0027223076247841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,41128,324,0.99 [0.88-1.11],0.864554211558715
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,41351,323,0.96 [0.80-1.15],0.6617816555478957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,41195,324,0.94 [0.71-1.24],0.6526861056348727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,40301,312,1.22 [0.98-1.52],0.0696792736542422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,41239,323,0.69 [0.47-1.01],0.0590687800939411
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,41603,324,0.64 [0.41-1.01],0.0539403351424811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,41239,323,1.17 [1.07-1.28],0.0003375788310986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,41195,324,1.06 [0.95-1.19],0.2943638820923552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,35697,278,1.07 [0.96-1.19],0.2418613768369453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,41542,321,1.31 [1.01-1.70],0.0394318799714751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,41710,326,1.04 [0.89-1.22],0.6073558806603435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,34908,268,1.23 [0.82-1.84],0.3112669150766007
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,34731,268,1.21 [1.01-1.45],0.0416181480090101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,35644,276,1.03 [0.91-1.18],0.6094451032358382
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],41045,321,1.00 [0.84-1.19],0.9907320069454906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,41247,323,1.14 [0.94-1.38],0.1922216529785365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,34825,269,0.98 [0.85-1.13],0.7540174477480883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,34731,268,1.28 [0.95-1.71],0.10441364382834
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,34731,268,0.91 [0.63-1.31],0.6037703923553007
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,40279,316,0.94 [0.72-1.22],0.6347140832384113
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,34825,269,0.82 [0.56-1.20],0.3052791932879947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,40807,318,1.01 [0.86-1.19],0.9072513190287996
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,35805,276,1.61 [1.28-2.04],6.825880034200072e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,40219,316,0.92 [0.76-1.11],0.3642881171620914
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,35197,269,1.28 [1.12-1.47],0.0003214201997265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,35707,278,1.03 [0.88-1.22],0.6998151067742083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,41045,321,1.76 [1.32-2.34],0.0001308195739268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,41247,323,1.36 [1.08-1.71],0.0094792607025962
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,35197,269,1.02 [0.86-1.22],0.7999862075914735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,33779,269,0.98 [0.89-1.08],0.6418057113601761
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,40837,321,0.97 [0.82-1.15],0.7470088697244235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,41402,323,0.92 [0.74-1.16],0.4998433175665273
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,41045,321,0.81 [0.70-0.94],0.0065146750252657
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,34760,267,0.92 [0.72-1.18],0.5227154176172152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,35790,277,0.97 [0.88-1.08],0.6379534822661305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,34908,268,1.14 [0.96-1.35],0.1298777456395425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,41045,321,0.99 [0.80-1.24],0.953401059218726
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,35783,278,3.65 [2.21-6.05],4.884516220956779e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,35790,277,1.30 [1.04-1.63],0.0217230237559573
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,41274,322,2.24 [1.67-3.00],5.97228878946626e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,40998,323,1.02 [0.89-1.18],0.7359876511886145
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,41466,323,1.47 [0.90-2.38],0.1236267851410661
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,34892,262,0.92 [0.68-1.25],0.6031894370188282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,34760,267,0.79 [0.61-1.03],0.0850186112394725
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,35707,278,1.12 [0.92-1.36],0.2535199632552137
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,35805,276,0.99 [0.82-1.19],0.9190130633633906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",34908,268,1.26 [1.07-1.49],0.0051334879879713
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,41603,324,0.93 [0.87-1.00],0.0421582689228467
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,41023,321,0.82 [0.64-1.07],0.1391853385030019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,34731,268,1.06 [0.88-1.28],0.5504272019987002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,40496,312,1.16 [1.01-1.34],0.0385173681595418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,40219,316,0.98 [0.86-1.13],0.8246567252119033
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,40937,319,1.09 [1.01-1.18],0.0350169292224242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,35805,276,1.03 [0.94-1.13],0.5214175069174487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",35197,269,0.96 [0.76-1.22],0.7551567271339652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40502,311,1.14 [0.96-1.36],0.1376178677576735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,34908,268,1.30 [1.02-1.65],0.031760633583694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,34537,264,1.02 [0.81-1.27],0.8787417435148566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,40279,316,0.99 [0.84-1.16],0.8936242537358797
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,34825,269,1.20 [0.93-1.55],0.1635933976582308
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,35507,278,0.90 [0.62-1.32],0.5899051089108106
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,35790,277,1.34 [1.00-1.79],0.0493714619045739
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,34731,268,1.04 [0.89-1.20],0.6273556423141045
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,41530,325,1.19 [0.83-1.70],0.3464031657104136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,41247,323,0.67 [0.46-0.95],0.0269502422454355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,40496,312,0.90 [0.72-1.12],0.3323095832219562
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,35197,269,1.10 [0.95-1.27],0.1908788949673647
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,41247,323,1.08 [0.90-1.30],0.415706772635232
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,41195,324,1.28 [1.13-1.45],9.164669976977692e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,35096,275,1.25 [0.98-1.59],0.0772210625805395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,34602,264,1.05 [0.71-1.54],0.8150300630215983
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,40279,316,0.97 [0.79-1.18],0.7405148608491303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,35707,278,1.18 [0.82-1.69],0.3717545104771357
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,34760,267,1.06 [0.93-1.20],0.3840967767198291
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,35022,275,1.10 [0.86-1.40],0.4329586747987258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,35805,276,1.01 [0.86-1.18],0.9055973332531412
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,41574,325,1.43 [0.94-2.16],0.0950369679769382
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,35805,276,1.07 [0.68-1.67],0.7796349715611272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,41239,323,1.63 [1.25-2.12],0.0003018341450464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,35707,278,0.80 [0.56-1.15],0.2283634300990342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,35707,278,1.33 [0.95-1.87],0.1005990929651598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,35697,278,1.06 [0.79-1.40],0.7076747719113322
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,34602,264,0.98 [0.81-1.18],0.8153705529648234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,35697,278,1.17 [0.94-1.47],0.1586950612981315
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,41742,327,0.85 [0.66-1.08],0.1864431856395947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,35707,278,1.05 [0.90-1.22],0.5576705343906024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,35859,278,1.02 [0.90-1.15],0.7673600332648092
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,41545,319,3.80 [3.44-4.19],4.795987625551616e-158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,41045,321,1.87 [1.39-2.52],3.3620456648364745e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,41603,324,1.04 [0.88-1.23],0.6194580901238973
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,41239,323,1.03 [0.89-1.19],0.6872440734107101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,34602,264,0.94 [0.75-1.19],0.6182557555366399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",34602,264,1.00 [0.81-1.25],0.973808481189684
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",34731,268,1.08 [0.91-1.30],0.3803713414154559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",35096,275,1.02 [0.91-1.14],0.7735416544850314
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,41742,327,1.05 [0.92-1.20],0.489393292866028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,41402,323,1.01 [0.90-1.14],0.8253047090862045
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,40301,312,1.28 [0.91-1.79],0.1575902134380686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,41239,323,1.35 [0.96-1.90],0.0854848816596494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,41742,327,1.07 [0.81-1.41],0.641374138983124
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,34602,264,0.81 [0.59-1.12],0.2094212771745565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,35096,275,1.53 [1.06-2.20],0.0218581627633709
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,35864,278,1.09 [0.91-1.32],0.3495169909926157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,34602,264,1.14 [0.95-1.36],0.1605983291746969
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,35805,276,1.02 [0.93-1.13],0.6708584872846024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,41402,323,1.00 [0.92-1.08],0.9250129704353386
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",40301,312,1.15 [0.97-1.38],0.1085349116810472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,34892,262,1.01 [0.81-1.26],0.9568440700256764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,34602,264,0.91 [0.72-1.16],0.4503376662148837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,34731,268,1.25 [1.04-1.49],0.0149632605066616
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,34825,269,1.27 [0.99-1.61],0.0555071119281016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,41742,327,1.11 [0.73-1.71],0.620589516471311
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,41247,323,1.10 [0.93-1.30],0.281442280196256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,41247,323,1.05 [0.76-1.46],0.7566352769442242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,34908,268,1.53 [1.12-2.08],0.0072543078894858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,35096,275,0.84 [0.57-1.24],0.388242948422021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,35885,280,0.61 [0.40-0.94],0.0255784831962607
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,34825,269,1.04 [0.94-1.14],0.4341651224715445
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,35645,275,1.08 [0.96-1.21],0.2072705484620698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,40279,316,0.98 [0.82-1.17],0.8124395572264289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,34602,264,1.01 [0.81-1.26],0.9304959734591416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,34892,262,0.94 [0.77-1.14],0.5184242528288754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40979,321,1.04 [0.91-1.18],0.5905651281717699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,35885,280,1.20 [1.03-1.41],0.018903081076502
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",35859,278,1.18 [0.96-1.45],0.1215254999896861
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,41710,326,2.30 [1.79-2.95],8.552452284437189e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,41544,326,1.37 [1.10-1.69],0.0042826944752015
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,35453,273,0.78 [0.53-1.14],0.2003058728139652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,34731,268,0.88 [0.70-1.09],0.2367283905554216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,34892,262,1.29 [1.13-1.49],0.0002848827103421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,34825,269,1.09 [0.98-1.20],0.1005138863046944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,35805,276,1.00 [0.90-1.10],0.9444185139525731
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,35707,278,1.11 [0.89-1.38],0.3415650060353871
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,34602,264,1.02 [0.91-1.16],0.7047633318407319
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40937,319,1.57 [1.12-2.20],0.0093876628025904
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,35096,275,1.03 [0.78-1.37],0.8235158896263488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,35885,280,0.69 [0.43-1.09],0.1116768083208629
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PI3,Elafin,40703,323,1.08 [0.91-1.29],0.3667813991497705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",35805,276,1.04 [0.90-1.20],0.6235578800898782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,40726,315,1.15 [0.87-1.52],0.3134274888686127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,41195,324,1.13 [0.97-1.33],0.1144015973761293
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,41247,323,2.17 [1.58-2.98],1.873139867969103e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,34825,269,1.04 [0.85-1.28],0.6864967613692221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,41247,323,1.43 [1.13-1.81],0.0032284885808947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,41239,323,1.31 [1.09-1.57],0.0035621919801992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,35096,275,0.91 [0.77-1.07],0.2688940483385032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,34537,264,0.99 [0.85-1.15],0.8660054875705387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,35859,278,1.13 [0.73-1.75],0.5721797833269253
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,34731,268,1.22 [1.01-1.47],0.0350673445342175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,41273,322,1.03 [0.89-1.20],0.6513729112395321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,35197,269,0.96 [0.82-1.13],0.6174800129202638
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,40937,319,1.05 [0.89-1.25],0.5457786872553113
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,41351,323,1.70 [1.19-2.44],0.0035793229347014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,41679,327,1.21 [0.97-1.51],0.0953860494061999
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",41149,322,1.20 [1.03-1.41],0.0220078586945398
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,41402,323,1.00 [0.89-1.11],0.9308362991894088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,41247,323,1.07 [0.79-1.45],0.6633415819343381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,41613,326,0.73 [0.60-0.88],0.0011061122675737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,41247,323,1.31 [0.98-1.76],0.0674700174183179
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,40945,320,2.50 [1.78-3.50],1.0590233605399548e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",35790,277,0.81 [0.67-0.98],0.0281041563965332
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",34825,269,1.08 [0.84-1.39],0.5634055138802048
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",35790,277,1.00 [0.89-1.12],0.9833133066438152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,35790,277,1.05 [0.89-1.24],0.5544709852680577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,34996,272,1.00 [0.58-1.70],0.9882414412866888
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,40279,316,0.99 [0.74-1.33],0.9637386118921596
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,41239,323,1.10 [0.87-1.38],0.430917341165496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,41239,323,1.03 [0.89-1.19],0.7248756075737929
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,35732,277,1.05 [0.86-1.28],0.6360623436260766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,41597,327,0.86 [0.66-1.12],0.2611106685595005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,40301,312,1.13 [0.86-1.49],0.3775086672932726
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,35790,277,0.78 [0.51-1.21],0.274890297241773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,41195,324,0.98 [0.87-1.11],0.7653555424378123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,41557,326,1.96 [1.32-2.89],0.0007480570453902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,41109,320,0.95 [0.77-1.17],0.6371503045817779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,41056,321,0.99 [0.94-1.04],0.6431961479869459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,34731,268,1.09 [0.97-1.23],0.1424698577783799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,34731,268,1.11 [0.91-1.35],0.3053188717136075
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,34892,262,1.12 [0.90-1.39],0.3235778352954791
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,40212,316,1.03 [0.94-1.13],0.4829441875514983
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,35885,280,1.05 [0.88-1.26],0.5844174699304105
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,35790,277,1.08 [0.94-1.25],0.2963932552855595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,41202,322,1.03 [0.99-1.07],0.1173249374830761
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,34908,268,1.28 [1.06-1.56],0.0119994340851356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,34760,267,0.90 [0.69-1.19],0.4671615621921448
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40496,312,0.97 [0.89-1.06],0.5386565976240305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,41045,321,0.74 [0.39-1.40],0.3494798755025401
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,41351,323,0.91 [0.64-1.30],0.6192526459334717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,34825,269,1.46 [1.19-1.80],0.0003084496362554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,34825,269,0.98 [0.65-1.45],0.9036362060238134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",41045,321,1.60 [1.31-1.94],2.7675364636298745e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,34908,268,0.94 [0.79-1.11],0.4572066669645854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,35885,280,0.73 [0.49-1.09],0.1229834106943279
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,40502,311,1.02 [0.76-1.36],0.9118283134979942
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,41402,323,0.81 [0.60-1.08],0.1532053996938258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,35864,278,0.79 [0.58-1.08],0.1424408928846572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,35639,274,1.07 [0.93-1.23],0.3275023867945935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,41603,324,1.03 [0.84-1.27],0.7499242137149895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,41260,324,0.99 [0.89-1.10],0.8336289087498049
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,35197,269,0.97 [0.80-1.18],0.7802536294138699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",35864,278,0.97 [0.81-1.16],0.7261172970684724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,34825,269,1.06 [0.75-1.51],0.7408981866260018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,40301,312,1.21 [0.91-1.61],0.1984705491795468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,34825,269,1.06 [0.89-1.27],0.5063608561280704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,35859,278,1.06 [0.85-1.32],0.5885465756755932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,41045,321,1.03 [0.88-1.21],0.7180059997512243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,35697,278,0.97 [0.84-1.12],0.6781555964541393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,41351,323,0.98 [0.88-1.08],0.6450020350755821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,35197,269,1.06 [0.91-1.23],0.4617574257967113
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,35805,276,0.94 [0.81-1.09],0.4142146144742186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,35805,276,1.34 [1.03-1.73],0.0264574600415712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,41239,323,1.01 [0.89-1.14],0.9355404216982788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,41710,326,0.99 [0.89-1.10],0.8483616645618384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,35707,278,1.05 [0.96-1.16],0.2825484679651291
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,40937,319,1.14 [0.90-1.45],0.2749580081927879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,34892,262,0.96 [0.82-1.13],0.6271069306372735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,41158,321,0.97 [0.88-1.07],0.5086891066068736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,40301,312,1.24 [1.08-1.43],0.0020877419866366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,34602,264,1.07 [0.67-1.69],0.777923515134253
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,35864,278,1.34 [1.01-1.80],0.0458819577585255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,35697,278,0.90 [0.68-1.20],0.476836568977063
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,41491,325,1.49 [1.11-1.99],0.0072387827114837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,40092,311,1.02 [0.91-1.14],0.7764741678616294
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,35282,276,1.02 [0.85-1.22],0.8426648549737779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40496,312,1.12 [0.98-1.28],0.1067198855257863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",41710,326,0.94 [0.82-1.09],0.4080644567447588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,41611,321,0.99 [0.84-1.17],0.92240856329582
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,40496,312,1.14 [0.82-1.58],0.4510696767952292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,41202,322,1.03 [0.67-1.57],0.904225354961988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,35864,278,1.23 [0.99-1.52],0.0652385674142997
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,35864,278,0.81 [0.64-1.02],0.0750874852955681
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40496,312,1.12 [0.94-1.34],0.2041034325368209
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,34892,262,0.93 [0.64-1.37],0.7198360803559993
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,41239,323,0.94 [0.83-1.05],0.2690849430672735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,35720,277,1.03 [0.90-1.19],0.6402566303554458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,40496,312,0.88 [0.69-1.13],0.3180850164691986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,34731,268,1.17 [0.94-1.46],0.1707623654228987
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,35096,275,0.98 [0.89-1.07],0.6656046625807173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,40301,312,1.15 [1.00-1.34],0.0524729131887809
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,41603,324,1.05 [0.93-1.20],0.4197186558163664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,35790,277,1.13 [0.90-1.41],0.291403674620094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,41330,322,0.70 [0.48-1.04],0.0762999823040284
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,34731,268,0.87 [0.60-1.25],0.4410090384191329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,41195,324,1.02 [0.86-1.21],0.8267852366829611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,35912,278,0.69 [0.44-1.08],0.1046078247167494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,34848,275,1.05 [0.89-1.24],0.5601765582685194
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,34825,269,1.14 [0.90-1.44],0.2747148013733054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,34908,268,1.56 [1.16-2.11],0.0037344724271531
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,41390,323,1.12 [0.94-1.34],0.2049601760790223
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,34825,269,1.09 [0.79-1.51],0.584483054032365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,41111,322,1.01 [0.79-1.30],0.9170022056008202
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,35790,277,1.03 [0.77-1.40],0.8290997150252064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,41074,321,1.08 [0.85-1.38],0.5050567753868447
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,40279,316,1.01 [0.92-1.10],0.8989884505833441
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,41611,321,0.81 [0.54-1.20],0.2845458118750821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,40192,316,1.42 [1.21-1.68],3.106736884187053e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,35197,269,0.81 [0.53-1.25],0.3416905535249105
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,35532,274,2.08 [1.55-2.77],7.655879952354829e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,35707,278,1.15 [0.91-1.44],0.2434981261409657
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,35707,278,1.02 [0.98-1.07],0.2988147950498671
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,40937,319,1.01 [0.93-1.10],0.7766566342312701
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,41195,324,1.20 [1.05-1.36],0.0064718322070206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,40301,312,1.09 [0.88-1.34],0.4380200132588836
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,34602,264,0.87 [0.59-1.29],0.4857210258829623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,35805,276,1.31 [1.06-1.61],0.01183035220212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,34892,262,1.02 [0.82-1.26],0.8901826106509801
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,41045,321,1.05 [0.88-1.25],0.5666907150441436
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,40877,319,1.26 [0.97-1.64],0.0795853536745376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,40750,319,1.48 [1.14-1.93],0.0036460654803336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,41195,324,1.21 [1.01-1.46],0.0404252330909078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,34825,269,1.17 [0.96-1.41],0.114520699589671
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,41195,324,1.05 [0.95-1.17],0.3616660819847591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,40301,312,0.98 [0.83-1.17],0.8562950440572045
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,33850,270,0.97 [0.87-1.08],0.6109292013345382
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",40279,316,1.11 [0.80-1.54],0.5330141461976814
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,40931,319,1.99 [1.51-2.62],1.0200424021275003e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,34560,267,1.00 [0.80-1.24],0.9889990353506036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,35859,278,0.88 [0.76-1.01],0.0737176313772823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,34892,262,0.93 [0.80-1.08],0.3550702589505943
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,41195,324,1.10 [0.87-1.39],0.4303122787041108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,40279,316,1.39 [1.07-1.80],0.0142376845066745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,40502,311,1.27 [1.04-1.54],0.0182021158460104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,34825,269,1.07 [0.86-1.32],0.5645498517563354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40937,319,1.15 [1.02-1.30],0.0268695357060788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,41341,322,0.96 [0.86-1.07],0.4516803426975858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,34759,267,0.97 [0.71-1.33],0.8729234974298091
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,35859,278,0.69 [0.47-1.03],0.0683196155543598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,35864,278,5.55 [3.86-7.99],2.3786491926108635e-20
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,41742,327,1.38 [0.98-1.93],0.0647541826821503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,35707,278,1.26 [1.00-1.59],0.0459184521999509
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,35707,278,1.69 [1.10-2.59],0.0160296563512225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,41126,324,1.89 [1.27-2.82],0.0016887115532688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40797,319,1.14 [0.84-1.54],0.4130008776910314
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,35790,277,0.83 [0.60-1.14],0.244913433002993
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,41742,327,1.54 [1.04-2.29],0.0301034312353599
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,35859,278,0.88 [0.61-1.25],0.4719125483657531
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,35096,275,1.02 [0.84-1.23],0.8771664569223576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,40094,314,1.12 [0.93-1.34],0.2240490767724513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,35197,269,1.26 [0.99-1.60],0.0609638580816779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,41195,324,1.24 [1.00-1.53],0.0500746320610309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,41424,321,0.99 [0.91-1.08],0.8370226193701407
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,41603,324,0.86 [0.65-1.13],0.2737014281511296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,35697,278,1.09 [0.91-1.31],0.3276364196366047
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,40279,316,1.28 [1.09-1.51],0.0031846129007483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,34908,268,1.13 [0.86-1.48],0.3822287629336073
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,34731,268,1.00 [0.89-1.12],0.9670687076957644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,35912,278,1.38 [1.12-1.71],0.002499431156292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,41047,322,1.06 [0.84-1.33],0.6207593575206011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,41294,323,2.27 [1.61-3.21],3.1904121478770087e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,35181,270,1.22 [0.99-1.51],0.0622637188274016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,35859,278,0.95 [0.76-1.18],0.623546190741942
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,35859,278,0.97 [0.88-1.08],0.6357379735421749
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,35859,278,0.95 [0.83-1.09],0.4378069599456476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,35697,278,0.96 [0.79-1.16],0.656819925930231
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,34731,268,1.01 [0.84-1.20],0.9322377105236715
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,40496,312,1.00 [0.89-1.13],0.9731212045969734
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,34731,268,1.08 [0.96-1.21],0.2078976448785257
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,34760,267,1.10 [0.92-1.32],0.3131122770478004
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,35697,278,1.18 [0.96-1.45],0.1201889399980229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,41195,324,0.74 [0.60-0.92],0.0072206786110453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,40279,316,0.89 [0.72-1.11],0.3023450355239769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,35096,275,1.02 [0.88-1.19],0.7713571789016808
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,40301,312,1.03 [0.87-1.22],0.7233493040699528
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,40496,312,1.11 [0.94-1.31],0.2205993157270274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,34892,262,1.01 [0.86-1.20],0.8780329246715167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,40301,312,1.07 [0.86-1.32],0.536015382274438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,35197,269,1.02 [0.82-1.26],0.8701706404762868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,34825,269,0.91 [0.62-1.35],0.6439902964753187
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,35697,278,1.22 [1.01-1.49],0.0433250281908117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,34908,268,1.06 [0.85-1.32],0.6308518467768747
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,34760,267,0.94 [0.65-1.35],0.7299687794517771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,40301,312,1.11 [0.92-1.35],0.2852800350947465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,34825,269,0.98 [0.83-1.17],0.83437597854862
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,35197,269,0.93 [0.74-1.17],0.5316408500180299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,40301,312,1.21 [0.93-1.57],0.1564709774013262
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,41466,323,1.03 [0.84-1.26],0.7938708990558511
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,40279,316,1.12 [0.84-1.49],0.4471337936492631
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,34602,264,0.79 [0.59-1.04],0.0948655998189804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,40301,312,1.26 [1.10-1.45],0.0009080822625382
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,35805,276,1.68 [1.34-2.11],6.545427768597086e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,40276,317,1.26 [1.04-1.53],0.0208935701177138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,35805,276,1.00 [0.86-1.17],0.9696223284599634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,34731,268,1.04 [0.81-1.33],0.7644562181833305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,34602,264,0.95 [0.73-1.23],0.6909036039389481
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,34892,262,1.11 [0.95-1.28],0.1777814677633931
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,41045,321,1.13 [0.99-1.28],0.0624967148243202
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,41045,321,1.46 [1.24-1.71],3.890423461133721e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,35707,278,1.12 [0.94-1.34],0.1924340783375049
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,34825,269,1.05 [0.89-1.24],0.5543155568751201
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,34908,268,1.01 [0.90-1.14],0.8218591690706372
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,35697,278,1.39 [1.18-1.62],5.157473579114178e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,40502,311,1.28 [1.07-1.52],0.0060548729497268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,34908,268,0.79 [0.45-1.39],0.4143987277545384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,35805,276,1.08 [0.90-1.29],0.3954958424834072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,40991,319,1.39 [1.17-1.67],0.0002612269730927
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,41742,327,1.28 [1.10-1.49],0.0017897471886104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,41742,327,1.35 [1.18-1.56],2.6390199412668845e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,35697,278,1.03 [0.77-1.37],0.8306534031748772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,41274,322,1.27 [1.04-1.53],0.0162276930312462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,34825,269,1.11 [0.89-1.38],0.3647869125535345
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,41247,323,2.67 [1.98-3.60],1.2311620191223635e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REN,Renin,41239,323,1.10 [0.98-1.24],0.1169140275972102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,34825,269,1.11 [0.83-1.48],0.4808744763080573
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,34602,264,0.85 [0.60-1.21],0.3639985842037889
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,41045,321,0.79 [0.61-1.02],0.0670759894048736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RETN,Resistin,41139,323,1.40 [1.13-1.73],0.0023064812866827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",34731,268,0.72 [0.54-0.97],0.0315150665679037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,35697,278,1.53 [0.94-2.50],0.0889866472185895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,35805,276,0.93 [0.80-1.08],0.3307514841447895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,35197,269,0.90 [0.73-1.10],0.2903733733441362
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,41603,324,0.87 [0.64-1.20],0.4013884422642085
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,41603,324,1.24 [0.86-1.78],0.242847782120321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,35805,276,1.01 [0.83-1.22],0.9453000901820128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,40496,312,1.08 [0.93-1.24],0.3172085798368484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,40686,319,1.02 [0.94-1.11],0.6381848579319667
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,34825,269,0.97 [0.76-1.25],0.8286490633693092
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,35096,275,1.16 [0.93-1.46],0.1978470683281108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,41490,321,1.05 [0.89-1.23],0.5909670717055264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,35859,278,0.99 [0.88-1.12],0.9224880648610724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,34731,268,0.97 [0.82-1.16],0.7552633513175868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,35805,276,1.06 [0.88-1.27],0.5462188117165445
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,35033,272,1.02 [0.89-1.16],0.8040678341543944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,35885,280,1.44 [0.96-2.17],0.0781415413684432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,34908,268,1.21 [0.97-1.52],0.091395492409894
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,41046,321,1.01 [0.93-1.11],0.7710623940748621
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,34711,276,1.51 [1.02-2.23],0.0387990485332672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,35622,279,1.78 [1.46-2.18],2.2914196339213745e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,35805,276,1.00 [0.79-1.25],0.9697773564459096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,41555,325,2.67 [2.06-3.45],1.0545160685217161e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,34908,268,2.45 [1.93-3.13],4.0272848383295444e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,34825,269,1.31 [1.03-1.67],0.027120478907926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,34825,269,1.18 [0.89-1.57],0.2408925551687001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,35197,269,0.93 [0.77-1.12],0.4157298768026451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,40301,312,1.16 [1.01-1.35],0.0408611449303546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,35197,269,0.98 [0.79-1.21],0.8467824790023409
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,34908,268,1.03 [0.88-1.21],0.7152311227420592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,41274,322,3.36 [2.39-4.73],3.772671803076345e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,41603,324,1.39 [0.91-2.12],0.1301320167371058
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,34908,268,2.07 [1.08-3.97],0.0292369349316253
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,41239,323,1.57 [1.15-2.13],0.0045022088543865
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,41045,321,0.98 [0.78-1.24],0.8847570645119659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,34825,269,1.28 [0.91-1.79],0.1521899829329466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,35197,269,1.04 [0.88-1.22],0.6513702993605973
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,34892,262,1.17 [0.90-1.52],0.2273899603736466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,34908,268,1.57 [1.26-1.97],7.797272837115194e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,34731,268,1.04 [0.79-1.37],0.7551375865013438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,34892,262,1.04 [0.95-1.13],0.4547995480730765
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,40301,312,1.56 [1.40-1.75],4.163733372153909e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,40301,312,1.03 [0.89-1.20],0.6589896773822296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,34760,267,0.97 [0.86-1.11],0.6971048768694037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,40937,319,1.17 [0.88-1.56],0.2841954427973773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,41611,321,1.74 [1.24-2.44],0.0014488503247487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,41045,321,0.89 [0.63-1.26],0.5066429369429295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,34731,268,1.07 [0.87-1.33],0.5142637180069947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",35805,276,1.01 [0.89-1.15],0.8282571017694633
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,41611,321,1.11 [0.84-1.48],0.463547276421608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,40301,312,1.02 [0.92-1.12],0.7247841020373833
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,41603,324,1.03 [0.89-1.21],0.6780980974509865
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,34731,268,0.67 [0.45-1.01],0.0529263563674596
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,40922,321,1.11 [0.92-1.35],0.28622709491788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,40662,318,1.12 [0.99-1.28],0.079326626064596
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,34825,269,1.32 [0.97-1.79],0.0791727581420866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,35805,276,1.12 [0.91-1.38],0.2906377132810446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,40219,316,1.09 [0.93-1.27],0.2782375998663724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,35697,278,1.19 [0.98-1.46],0.085685438358918
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,41351,323,0.94 [0.79-1.12],0.4783499994902602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,35805,276,1.31 [1.04-1.63],0.020298465822916
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,40502,311,1.10 [0.92-1.30],0.2870841829989327
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,35912,278,0.94 [0.62-1.42],0.7691472401239436
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,35805,276,1.40 [1.00-1.97],0.0487483799006496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,34760,267,1.02 [0.81-1.28],0.8675006720951501
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,41195,324,1.06 [0.92-1.21],0.4122528377095755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,35197,269,0.93 [0.78-1.10],0.3785768081567859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,35734,277,0.96 [0.87-1.07],0.5025692573713102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,34731,268,1.40 [1.13-1.74],0.0020859315676219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,34731,268,0.89 [0.69-1.15],0.3689980505144449
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,35197,269,1.01 [0.86-1.20],0.867511544806089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,35805,276,1.21 [0.86-1.71],0.2676430008802055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,35795,277,0.97 [0.70-1.35],0.8527411682627322
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,41045,321,1.07 [0.95-1.20],0.2748535339920649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,41603,324,0.91 [0.66-1.27],0.5911518247434312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,40279,316,1.02 [0.86-1.21],0.7955405989443122
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,40158,312,2.21 [1.67-2.92],2.4244964754538298e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,41742,327,1.29 [1.03-1.62],0.0273025142697595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,41603,324,1.38 [0.98-1.94],0.0646689467080496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,41421,321,1.00 [0.73-1.35],0.975124225936772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,41274,322,0.95 [0.71-1.28],0.7357893767936527
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,41274,321,1.12 [0.93-1.34],0.2423957160353637
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,34731,268,0.81 [0.53-1.22],0.3137827931831738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,35096,275,1.79 [1.14-2.80],0.0112016195369364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,41341,322,1.01 [0.90-1.14],0.8179716779457636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,40496,312,1.24 [0.99-1.54],0.0598772971102929
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,34760,267,0.96 [0.82-1.13],0.6487236210913863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,41490,321,1.08 [0.88-1.33],0.4436625443593136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,34760,267,0.93 [0.72-1.20],0.5861763619080838
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,34892,262,0.87 [0.56-1.34],0.5280367037163942
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,34892,262,0.82 [0.57-1.17],0.2763684905603101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,34760,267,1.14 [0.91-1.43],0.2493177786089261
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,34908,268,0.95 [0.72-1.26],0.7419004894983228
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,40301,312,0.95 [0.83-1.09],0.4821019180669192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,34782,267,1.11 [0.88-1.40],0.3841887376107507
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,35859,278,1.27 [0.85-1.90],0.2385773469883819
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,34908,268,1.04 [0.92-1.18],0.5567526617676741
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,41195,324,1.15 [0.97-1.37],0.0967315151259387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCT,Secretin,34892,262,0.90 [0.70-1.16],0.4159699592507374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,41239,323,1.74 [1.40-2.16],5.744750344202377e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,41239,323,0.76 [0.62-0.94],0.0118344304396602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,35697,278,1.02 [0.92-1.13],0.6748396913918506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,35707,278,1.02 [0.86-1.21],0.7983843593036584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,35096,275,1.80 [1.43-2.27],8.055009743226718e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,34908,268,1.06 [0.91-1.24],0.4573793908951142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,34908,268,1.54 [1.23-1.93],0.0001559354147913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,41742,327,1.29 [1.06-1.56],0.0117986087607452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,35912,278,0.58 [0.34-0.97],0.0370073042477951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,35912,278,3.83 [2.60-5.65],1.1823492126648626e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,41390,323,0.97 [0.82-1.15],0.7422617634870305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,41195,324,0.88 [0.62-1.25],0.4892575295056196
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,41239,323,1.69 [1.16-2.44],0.0056884426271865
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,35096,275,1.79 [1.43-2.24],4.49991963880448e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,41045,321,1.46 [1.12-1.91],0.0058393243906659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,41603,324,2.23 [1.60-3.10],1.980084463086266e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,34825,269,1.41 [0.97-2.06],0.0752358236823878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,41613,326,3.99 [3.27-4.86],1.0631101291894186e-42
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,35805,276,0.86 [0.73-1.01],0.0612791107621769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,35197,269,1.12 [0.92-1.35],0.2666852465893274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,35717,277,1.71 [1.26-2.32],0.0005254560853361
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,41045,321,1.28 [0.93-1.75],0.1277577823577114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,35227,273,3.58 [1.16-11.04],0.0265819768352794
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,41742,327,1.18 [0.93-1.50],0.168549561466158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,40070,312,1.05 [0.97-1.15],0.2280240805175647
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,35787,276,2.57 [1.45-4.55],0.0012323794777053
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,35242,273,0.56 [0.35-0.91],0.019541695972541
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,35369,274,0.49 [0.32-0.75],0.0008726643080232
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,35912,278,0.83 [0.41-1.69],0.6049450685415121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,35912,278,2.55 [1.42-4.58],0.0017189824713622
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,40835,320,1.83 [1.63-2.06],3.953868619659148e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,41119,321,1.05 [0.94-1.17],0.4192619782701213
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,40502,311,1.03 [0.84-1.27],0.7566955531523472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,41468,322,1.05 [0.89-1.24],0.5600066357121413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,41710,326,1.31 [1.16-1.49],2.0779922076078945e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,40937,319,1.25 [0.93-1.68],0.1454152556355513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,35840,275,2.18 [1.01-4.71],0.0469006321347003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,35840,275,1.32 [0.88-2.00],0.1841993596541851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,41742,327,1.00 [0.86-1.15],0.984477852058372
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,35859,278,1.17 [0.98-1.39],0.0782864239685456
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,35368,272,1.04 [0.67-1.61],0.8606507219583144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,35225,272,1.49 [0.64-3.46],0.3593506695998096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,35840,275,1.30 [0.70-2.42],0.4048945648532046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,35197,269,1.01 [0.92-1.10],0.886066303383374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,35025,274,0.99 [0.67-1.45],0.9461571027770468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,35707,278,1.09 [0.89-1.33],0.3878492926187219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,40279,316,1.02 [0.87-1.19],0.8432050010209271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,40805,316,1.58 [1.17-2.14],0.0032219918119494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,34892,262,0.94 [0.63-1.39],0.7394323665634395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,41351,323,0.91 [0.63-1.30],0.5970179666348325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,41045,321,1.31 [0.87-1.97],0.2006272072164934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,41045,321,0.94 [0.82-1.08],0.3703003082421353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,40803,318,0.95 [0.75-1.20],0.6726595315186149
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,35096,275,0.94 [0.71-1.26],0.6870260319164139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,40301,312,1.03 [0.86-1.22],0.7491128779765528
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,40301,312,1.22 [1.01-1.48],0.037042735867898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,41239,323,1.08 [0.93-1.25],0.3297486455392796
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,35253,272,1.10 [0.90-1.35],0.3416759455821627
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,40301,312,1.05 [0.95-1.16],0.3718077424380686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,41195,324,1.34 [1.18-1.53],1.0026330193479043e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,34760,267,0.86 [0.69-1.07],0.166914237316069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,35707,278,1.13 [0.91-1.40],0.2577279301134962
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,34997,269,0.85 [0.75-0.97],0.0169763530554004
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,35790,277,0.97 [0.81-1.15],0.6973720493918875
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,35885,280,1.14 [0.91-1.44],0.2482553018885619
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,34602,264,1.01 [0.91-1.12],0.8146016575111615
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,34664,268,1.12 [1.00-1.26],0.0491609148927078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,34825,269,1.04 [0.79-1.35],0.7988917522428283
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,35864,278,2.39 [1.80-3.17],1.4769939413878702e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",41341,322,0.96 [0.85-1.08],0.4656482607276589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,35197,269,1.19 [0.92-1.54],0.1739939552872306
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,41286,323,1.17 [0.95-1.44],0.1448710540594815
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,41402,323,1.68 [1.34-2.09],5.199799062529284e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,41195,324,5.31 [4.24-6.64],2.029353583578285e-48
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,40279,316,1.13 [1.00-1.26],0.0424496875916012
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,41247,323,1.16 [1.05-1.28],0.0036159145345945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,41611,321,3.24 [2.63-3.99],1.1252606028236284e-28
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,41239,323,1.24 [0.88-1.76],0.2234180817063759
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,34908,268,1.96 [1.53-2.52],1.4140315077769536e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,41552,321,1.19 [0.85-1.65],0.3144042412570111
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,34908,268,0.97 [0.67-1.40],0.8638390094164157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,41340,325,1.09 [0.91-1.29],0.3549961999377199
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,41134,322,1.94 [1.58-2.38],1.8218179591809008e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,34825,269,1.10 [0.98-1.24],0.1161924175052485
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,41045,321,1.03 [0.92-1.15],0.6018506948836913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",40279,316,0.82 [0.67-1.01],0.0565580315005199
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,40496,312,1.10 [0.92-1.32],0.2860881975248821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,40861,319,0.88 [0.77-1.01],0.0711748033811902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,41402,323,0.94 [0.86-1.03],0.2131495833818141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,34731,268,0.86 [0.63-1.18],0.3538423725987915
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,35805,276,0.98 [0.87-1.09],0.6697810496637602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,40496,312,1.38 [1.16-1.64],0.0003080609177845
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,40301,312,2.57 [2.10-3.13],1.4342942255721132e-20
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,41195,324,1.27 [1.08-1.50],0.0046961945592105
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,40301,312,2.14 [1.79-2.56],6.846447909164135e-17
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,34731,268,1.06 [0.70-1.62],0.7671165098584495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,35697,278,1.07 [0.89-1.27],0.4811903377797885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,40279,316,1.16 [0.99-1.36],0.0635213273578147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,34892,262,0.94 [0.74-1.20],0.6409638330112166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,40279,316,1.04 [0.90-1.21],0.5766637768212681
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,34602,264,1.04 [0.85-1.25],0.7257533463724699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,34602,264,0.99 [0.77-1.27],0.9341001906481432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,40279,316,1.32 [1.02-1.72],0.0352959599562001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,41195,324,1.07 [0.90-1.29],0.4318156780527801
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,34892,262,1.07 [0.91-1.25],0.4130578737338545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,35864,278,0.86 [0.67-1.10],0.2186823142433598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,34731,268,0.98 [0.84-1.15],0.7905827364164355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,35096,275,1.01 [0.88-1.16],0.8903025408030566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,35707,278,1.11 [0.91-1.36],0.2995682408736111
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",34602,264,1.07 [0.88-1.31],0.4789795488001322
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,40279,316,1.05 [0.87-1.27],0.6026752482038022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,34825,269,1.08 [0.75-1.55],0.6831647431617174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,41611,321,1.61 [1.26-2.06],0.0001709051555287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,40502,311,1.45 [1.10-1.91],0.0075663690299439
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,35197,269,1.00 [0.87-1.16],0.9505532974707436
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,35707,278,1.06 [0.93-1.22],0.3687394837447014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,35596,277,1.09 [0.81-1.46],0.5782696032502579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,40301,312,1.04 [0.92-1.18],0.5104344623377239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,35697,278,1.01 [0.86-1.19],0.8961751926698822
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,35697,278,1.13 [0.91-1.40],0.2719024058399416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,41045,321,0.59 [0.37-0.95],0.0289663264338486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,40279,316,0.97 [0.84-1.11],0.6337393504920276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,34602,264,1.19 [0.98-1.43],0.0771351472661682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,35707,278,1.29 [1.13-1.49],0.0002956874035086
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,41611,321,1.55 [1.15-2.07],0.0034284480174493
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,41402,323,1.10 [0.85-1.42],0.4641294628438287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,41396,323,1.34 [1.11-1.62],0.0026862859069253
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,34825,269,1.21 [1.03-1.42],0.021529364338957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,41334,323,0.96 [0.82-1.11],0.5519630112134501
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,35697,278,1.11 [0.98-1.27],0.1031787352736175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,34760,267,0.98 [0.81-1.18],0.8194934932294865
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,35726,277,0.99 [0.88-1.12],0.8941012358163541
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,41239,323,0.95 [0.85-1.06],0.3906098267523947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,34760,267,1.03 [0.80-1.32],0.8130319373134296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,41351,323,0.99 [0.89-1.10],0.8115681901067962
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,35805,276,1.03 [0.84-1.25],0.8034591715819182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,35096,275,0.98 [0.88-1.08],0.6458826291756037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,40937,319,1.08 [0.93-1.25],0.3246627497001016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",34908,268,1.00 [0.70-1.44],0.9849539469584164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',35790,277,1.36 [1.17-1.59],7.442817241377914e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,34731,268,1.16 [0.99-1.37],0.0653449895562719
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,35096,275,0.99 [0.80-1.22],0.8975786670162665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,35707,278,1.21 [0.95-1.53],0.1170592201957564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,35697,278,1.09 [0.95-1.24],0.2206218964661064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,34908,268,1.28 [0.89-1.86],0.1855266271284574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,41239,323,1.00 [0.87-1.16],0.9753588941670036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],40411,316,1.12 [0.91-1.37],0.2850155456708508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",41247,323,1.20 [0.94-1.54],0.1510157443065815
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,35885,280,0.85 [0.67-1.07],0.1662346042559308
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,35805,276,0.99 [0.74-1.33],0.9656691769541392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,40301,312,1.77 [1.34-2.33],5.152669939721773e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,41420,321,1.06 [0.92-1.23],0.4051510222575338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,41184,322,1.13 [0.87-1.48],0.3449177317930509
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,41184,322,0.86 [0.67-1.11],0.251861563757358
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,34892,262,1.12 [0.91-1.39],0.2895653842942841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,35740,276,1.43 [0.91-2.22],0.1170631836835835
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,34892,262,1.37 [0.88-2.13],0.1627057186398913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,35805,276,1.00 [0.67-1.47],0.9836308174221072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,35805,276,1.10 [0.91-1.32],0.3203147524145417
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,41351,323,1.00 [0.87-1.15],0.9749736654285244
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,41253,323,0.91 [0.64-1.31],0.6158801510243032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPART,Spartin,35096,275,0.99 [0.85-1.16],0.9345277417244696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,35859,278,1.68 [1.20-2.35],0.0027788104493446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,41247,323,1.50 [1.20-1.86],0.0002642930945123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,35096,275,1.68 [1.26-2.24],0.0004049898330805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,41195,324,1.30 [1.13-1.50],0.0002336170526909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,41247,323,0.68 [0.51-0.92],0.0124468038203898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,41611,321,1.04 [0.86-1.25],0.674338566375144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,34731,268,0.82 [0.58-1.17],0.2794879079787215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,41113,319,2.08 [1.46-2.97],4.830595011380949e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,41402,323,1.31 [1.03-1.68],0.0290525083982081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,35707,278,0.90 [0.84-0.97],0.0053490557774167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,40937,319,0.60 [0.41-0.89],0.0105569482881752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,41274,322,1.31 [0.97-1.77],0.077920886472759
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,41056,321,1.14 [0.86-1.53],0.3626239155496027
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,41673,327,1.25 [1.01-1.55],0.0422685368207603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",34825,269,1.32 [1.04-1.67],0.0239449511593807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,34602,264,1.18 [1.00-1.39],0.0460963012944305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,35197,269,1.02 [0.89-1.17],0.7310760946670842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,35790,277,1.15 [0.97-1.35],0.1074808565211949
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,40496,312,1.02 [0.91-1.13],0.7663928491372745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",34760,267,0.96 [0.67-1.38],0.8245138308860143
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,35790,277,1.35 [1.07-1.70],0.0109909166036623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,41282,323,0.96 [0.88-1.04],0.3188005168009581
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,41045,321,1.14 [0.97-1.33],0.1080108832303353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,41195,324,1.02 [0.91-1.15],0.6964511080172577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,35859,278,1.15 [0.84-1.59],0.38656178775377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,40279,316,1.00 [0.85-1.19],0.957831232848411
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",34825,269,1.18 [0.88-1.60],0.2687210439275129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,41184,322,0.93 [0.85-1.01],0.0909126993692333
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,41390,323,0.98 [0.77-1.23],0.8445659965964666
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,34602,264,0.83 [0.54-1.27],0.3828841399646232
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,35707,278,1.03 [0.82-1.28],0.8079502638127608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,35096,275,1.00 [0.81-1.23],0.977512194786055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",41045,321,1.13 [0.90-1.41],0.285241461472669
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",41742,327,1.22 [0.88-1.68],0.2300018989141933
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",34825,269,1.23 [1.02-1.48],0.034169615051635
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,35864,278,1.37 [0.92-2.06],0.1248783041008666
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,35697,278,1.16 [0.87-1.55],0.3000777362592303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,40861,319,1.10 [0.94-1.28],0.2401318831333352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,34825,269,1.10 [0.95-1.28],0.2130479368404045
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,41045,321,1.00 [0.93-1.08],0.946714891462219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,34602,264,1.12 [0.95-1.32],0.1657507565191507
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,41603,324,1.97 [1.63-2.38],4.058900947321648e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,41192,323,1.45 [0.97-2.18],0.0712593503261972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,34760,267,1.00 [0.86-1.18],0.9700764227034132
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,41181,322,1.00 [0.86-1.16],0.9985166643918524
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,40502,311,1.00 [0.87-1.15],0.9517056749935288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,40279,316,1.06 [0.90-1.25],0.4686528510750476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,41239,323,0.95 [0.85-1.07],0.3853962411939321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",34602,264,1.09 [0.97-1.23],0.1514477468709633
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,40301,312,1.03 [0.87-1.22],0.7167111322208426
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,34892,262,1.03 [0.77-1.36],0.8513369567330371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,35790,277,1.17 [0.90-1.52],0.246527197845507
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,41045,321,1.03 [0.88-1.21],0.6795638724768078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,34825,269,1.08 [0.82-1.42],0.5979964023226765
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,40301,312,1.13 [0.98-1.30],0.0820789535112194
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,34825,269,1.08 [0.85-1.37],0.5219171169039982
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,41195,324,1.17 [0.97-1.42],0.1071110803941178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,35805,276,0.97 [0.84-1.13],0.6967984312015493
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,40301,312,1.07 [0.85-1.33],0.5770157597247272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,35707,278,1.09 [0.83-1.44],0.5354775063587398
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,40301,312,1.04 [0.91-1.18],0.5788239732014699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,41603,324,1.00 [0.93-1.08],0.9236024141724636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,41195,324,1.16 [0.99-1.37],0.0630527594774072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,34825,269,1.00 [0.84-1.19],0.9923240048632368
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,41603,324,0.88 [0.73-1.06],0.1731202340938109
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",35805,276,1.09 [0.91-1.30],0.3453902698230774
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,40502,311,0.85 [0.70-1.05],0.1273124407807489
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,41247,323,1.08 [0.77-1.52],0.6566334745111831
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,35697,278,1.27 [0.99-1.63],0.0584390238034547
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,34907,273,1.25 [0.88-1.76],0.2091377803732841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,34892,262,1.08 [0.90-1.30],0.4012669554323601
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,35707,278,1.88 [1.55-2.29],1.7008809457466802e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,35096,275,0.93 [0.75-1.14],0.46338345976437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,34760,267,0.99 [0.81-1.22],0.9524829647925148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,35790,277,0.87 [0.63-1.20],0.38992310819419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,35859,278,0.96 [0.82-1.12],0.5756514359595948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,35197,269,0.96 [0.86-1.08],0.5096017556564822
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,41045,321,0.97 [0.89-1.06],0.4964768623435595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,36593,289,0.87 [0.61-1.26],0.4737160023507377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,35697,278,0.98 [0.73-1.31],0.8847927978821596
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,41045,321,1.26 [0.96-1.65],0.098130474596291
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,34602,264,0.88 [0.72-1.08],0.2346427960788114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,35732,277,1.23 [0.96-1.58],0.099908610349213
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,40496,312,1.03 [0.89-1.19],0.6721666769898536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,35197,269,1.01 [0.83-1.23],0.9494791556672496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,40279,316,1.04 [0.92-1.18],0.5156103794808402
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",34892,262,0.91 [0.77-1.08],0.2811156584776468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",35697,278,1.02 [0.75-1.38],0.8922069671465941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,35790,277,1.13 [0.95-1.35],0.1706988046593101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,40279,316,1.08 [0.87-1.34],0.4843376829025048
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,41045,321,0.99 [0.89-1.10],0.8442164346288191
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,41195,324,1.07 [0.95-1.21],0.2635926136161735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,35096,275,1.08 [0.94-1.23],0.2813271677398931
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,40937,319,1.04 [0.94-1.14],0.4901968473101334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,40937,319,1.05 [0.93-1.19],0.4514487939673071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,40301,312,1.05 [0.93-1.18],0.4369349474496307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,34892,262,1.06 [0.83-1.34],0.6504545587633201
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,40875,319,1.04 [0.94-1.15],0.4243935182856135
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,40502,311,1.01 [0.89-1.14],0.8821182848254365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,35159,279,1.45 [1.10-1.90],0.0078122453485262
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,41673,327,1.24 [0.91-1.69],0.1704685091478435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,35859,278,2.39 [1.97-2.89],4.4449364925576565e-19
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,35197,269,1.05 [0.87-1.27],0.6308674627616544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,35859,278,1.05 [0.72-1.54],0.7957066883408145
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,40279,316,1.06 [0.99-1.13],0.1160252976401325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",34892,262,0.99 [0.72-1.34],0.9315229791456788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,35697,278,1.26 [1.11-1.43],0.0002752887585746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,40279,316,1.12 [0.99-1.25],0.061063296087068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,34731,268,1.12 [0.86-1.45],0.4003215330660088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,41351,323,1.11 [0.71-1.74],0.649706231643477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,34825,269,1.27 [0.87-1.85],0.2154349692009378
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,35132,269,1.02 [0.91-1.14],0.7485526604673984
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,34892,262,0.94 [0.74-1.18],0.5751525945582205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,35197,269,0.91 [0.66-1.25],0.5529087226831818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,35912,278,0.55 [0.32-0.92],0.0243034206207175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,34760,267,0.94 [0.77-1.16],0.574321051953588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,41057,319,1.09 [0.97-1.23],0.1464267267053706
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,41341,322,1.18 [1.00-1.40],0.0544964722230615
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,41202,321,1.31 [1.08-1.59],0.0059667981582288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,41129,320,0.93 [0.67-1.28],0.6368272948066118
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,41225,323,1.34 [1.10-1.63],0.003312013330973
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,41401,321,1.38 [1.07-1.76],0.0117129464364915
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,35697,278,1.02 [0.92-1.13],0.7075341018402208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,41195,324,1.31 [1.07-1.60],0.008866970177171
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,41636,325,1.32 [1.03-1.68],0.0271220952880296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,35697,278,0.95 [0.77-1.19],0.6712962268530358
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,40995,320,0.86 [0.59-1.24],0.407563122944248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,34825,269,1.58 [1.05-2.37],0.0269427930885475
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,41351,323,1.68 [1.28-2.22],0.0002140092165597
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,41742,327,1.27 [0.92-1.74],0.1449969976318283
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,41176,322,0.94 [0.83-1.07],0.3704331685846205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,35885,280,1.34 [0.87-2.06],0.1863214393887308
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,34537,264,0.98 [0.86-1.13],0.7863998072175679
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,41239,323,2.01 [1.49-2.71],4.95915079478802e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,41247,323,1.10 [0.85-1.44],0.4576299123649117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,41257,321,0.84 [0.67-1.04],0.1065790692262384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,41052,322,1.61 [1.20-2.15],0.001578561331478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,40502,311,0.94 [0.72-1.21],0.6180034753060217
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,34731,268,1.01 [0.91-1.12],0.884761490877174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,34561,267,1.24 [0.89-1.72],0.2059806937060487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,35631,278,1.03 [0.90-1.17],0.6712646436438056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,41603,324,1.57 [1.12-2.21],0.0095054841746204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,40056,309,1.00 [0.92-1.09],0.918189151135041
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,41742,327,1.41 [1.08-1.85],0.0125924668004364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",40203,316,1.41 [1.17-1.70],0.0003545441258714
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,35197,269,1.89 [1.68-2.13],1.7438188390631187e-25
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,41390,323,1.49 [1.20-1.86],0.0003986079721644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,35859,278,1.05 [0.79-1.40],0.7295119869038799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,35790,277,1.04 [0.91-1.18],0.6013297199469756
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,40793,317,1.71 [1.23-2.37],0.0014278231849964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,35859,278,1.21 [0.86-1.71],0.2741082369064472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,41402,323,1.04 [0.97-1.12],0.3110051324618385
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,41247,323,0.84 [0.65-1.08],0.1719872967025859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,41113,321,2.39 [1.55-3.70],8.739769653055356e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,41351,323,0.98 [0.87-1.11],0.779953970164992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,34760,267,0.83 [0.61-1.12],0.2156014649123576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",35197,269,1.49 [1.23-1.80],4.388079739378252e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,34825,269,1.59 [1.05-2.39],0.0268545623162344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,35197,269,1.24 [0.75-2.05],0.404630807653225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,41710,326,1.13 [0.96-1.34],0.1323740855129374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,34825,269,1.08 [0.72-1.63],0.7084346481409471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,34892,262,1.00 [0.81-1.25],0.9779508613478416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,35197,269,0.93 [0.74-1.16],0.5221040386840221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,34731,268,0.97 [0.75-1.25],0.7893366772506171
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,34731,268,0.89 [0.71-1.12],0.3359972272540767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,35707,278,1.00 [0.89-1.11],0.930306432627526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,35697,278,0.95 [0.81-1.12],0.5656150688707718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,34908,268,0.87 [0.72-1.06],0.1606181994659598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,35805,276,1.13 [0.90-1.43],0.2903287839386224
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,34602,264,1.09 [0.82-1.46],0.5452876026257858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,34760,267,0.97 [0.83-1.14],0.7332308743213511
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,35717,277,0.96 [0.71-1.29],0.7722092613593541
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,41045,321,0.88 [0.79-0.98],0.0211239405505166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,40740,318,1.36 [1.05-1.78],0.0217863735299286
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,41247,323,1.14 [1.00-1.30],0.0445012106587667
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,41390,323,1.65 [1.36-2.01],5.74556861356388e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,40436,311,1.86 [1.66-2.09],9.462990973007848e-26
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,35707,278,1.24 [1.00-1.54],0.0472967741055911
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40496,312,1.00 [0.76-1.31],0.9991733223480316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,35096,275,0.96 [0.80-1.16],0.697763227068025
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40937,319,2.17 [1.78-2.64],1.8482415781748284e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40937,319,1.43 [1.29-1.58],1.3195329337697776e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,41315,323,1.13 [0.93-1.39],0.22309027153337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41710,326,1.69 [1.33-2.14],1.4221864206330795e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,41202,322,1.04 [0.74-1.46],0.8201568664003247
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,41351,323,1.13 [0.86-1.50],0.3788173304681806
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,41274,322,3.94 [3.47-4.46],5.931044829764776e-101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40496,312,3.52 [3.14-3.95],3.4824741546001107e-102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,41274,322,2.17 [1.62-2.91],2.491195596099944e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,35096,275,2.77 [2.12-3.61],5.375717256820691e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,41611,321,1.79 [1.35-2.39],5.7993397736026574e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,41247,323,2.16 [1.61-2.90],2.618280076332732e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,41247,323,1.78 [1.57-2.03],8.151365490193064e-19
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,41603,324,1.38 [0.97-1.97],0.0747302920761625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,41636,325,5.02 [4.22-5.96],2.9991121712848677e-75
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40937,319,1.67 [1.46-1.92],2.796397056023849e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,41603,324,2.91 [2.52-3.36],3.3072292931795977e-48
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40937,319,4.11 [3.72-4.54],1.6999937253891992e-172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,41710,326,1.69 [1.16-2.48],0.0064048649936185
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,41195,324,1.40 [1.19-1.64],4.257185266696743e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,41710,326,1.16 [0.82-1.63],0.3961680489411635
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,41402,323,1.17 [0.81-1.70],0.3934550606781276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,41672,327,0.95 [0.66-1.38],0.8023699910685237
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,40937,319,1.09 [0.92-1.29],0.3077872061685858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,35864,278,3.08 [2.45-3.86],3.3354225646276174e-22
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,35790,277,1.05 [0.92-1.19],0.491210499654212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,35864,278,0.94 [0.72-1.21],0.6158763772775397
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",40502,311,1.01 [0.89-1.14],0.8826941671979316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,35197,269,1.28 [0.94-1.73],0.117811315164121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,40937,319,0.92 [0.72-1.16],0.4622333404169622
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,41247,323,0.68 [0.46-1.00],0.0491342245150721
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,35859,278,1.02 [0.88-1.19],0.760132160918273
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,35707,278,0.98 [0.88-1.08],0.6452905414388417
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",34602,264,0.79 [0.60-1.04],0.0931896829179121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,34825,269,1.11 [0.96-1.29],0.1496893462313164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,34908,268,1.26 [1.04-1.51],0.0153728039336094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,40301,312,1.23 [0.98-1.54],0.0756578776274183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,34825,269,1.18 [1.03-1.34],0.0134255100383902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,34330,271,1.08 [0.87-1.35],0.4955965748338649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,40502,311,1.16 [0.87-1.54],0.3200801185640229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,34892,262,0.93 [0.66-1.32],0.6800253348609024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,34892,262,1.11 [0.85-1.45],0.4228336778188221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,35096,275,0.99 [0.89-1.10],0.8324202638498356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,35859,278,2.29 [1.54-3.42],4.858847495676648e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,34731,268,0.98 [0.75-1.28],0.8591049472329106
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,40301,312,1.17 [1.03-1.33],0.0173067477666408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,40939,318,1.26 [1.03-1.54],0.0265432573492472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,35197,269,1.04 [0.90-1.20],0.5641715484405169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,40279,316,1.09 [0.86-1.38],0.4791186758052392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,34731,268,1.36 [1.16-1.59],0.0001557722835173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,34602,264,0.95 [0.78-1.15],0.577778436690402
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,41646,325,1.08 [0.90-1.30],0.417611210980334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,35805,276,1.10 [0.83-1.46],0.5083984801587446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,34825,269,1.20 [0.79-1.81],0.3947126902793585
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,40496,312,1.00 [0.85-1.16],0.954752941756948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,41195,324,1.00 [0.87-1.15],0.981672550723804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",34825,269,1.33 [1.03-1.72],0.0280635399826413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,34731,268,1.03 [0.81-1.31],0.784853395233015
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,35197,269,1.05 [0.92-1.20],0.4544955233484039
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,35864,278,0.84 [0.73-0.98],0.0242757231660521
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,41202,322,1.11 [0.92-1.34],0.2845292928687276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,35885,280,1.10 [0.89-1.36],0.3733814198107408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,41247,323,2.12 [1.60-2.81],1.5468545183569716e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,41611,321,1.06 [0.91-1.24],0.4737524065931714
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,41195,324,0.86 [0.76-0.97],0.0145630273703311
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,35127,269,1.06 [0.89-1.26],0.5379399399918492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,35707,278,1.04 [0.93-1.15],0.5244461674913768
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,34602,264,0.98 [0.79-1.21],0.8347273703814625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,34892,262,0.92 [0.78-1.09],0.362127624565234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,41195,324,1.01 [0.90-1.14],0.8343375725043947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,35697,278,1.07 [0.94-1.22],0.3328615695430281
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,34731,268,0.95 [0.74-1.21],0.6769868379114401
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,34825,269,1.15 [1.00-1.31],0.0460502473795231
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,35805,276,1.08 [0.91-1.28],0.3784688587556006
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,41239,323,1.06 [0.94-1.21],0.3336927242158086
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,40502,311,1.16 [1.01-1.33],0.0420264732472224
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,34731,268,1.00 [0.74-1.34],0.9948204638550436
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,40502,311,1.01 [0.87-1.18],0.8683336740289197
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,34731,268,0.86 [0.67-1.11],0.2517623433190684
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,34760,267,0.94 [0.82-1.07],0.3351503746279669
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,35707,278,1.05 [0.94-1.18],0.4060301576918891
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,34825,269,1.06 [0.79-1.41],0.7009014910867732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,40212,316,1.06 [0.93-1.21],0.3674142242956285
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,34892,262,1.03 [0.81-1.31],0.7817795631295268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TTN,Titin,34731,268,1.06 [0.90-1.25],0.4590728751792506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,35520,274,0.64 [0.40-1.00],0.0520401242301394
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,34760,267,1.08 [0.72-1.64],0.7068610897555825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,35864,278,1.02 [0.89-1.16],0.8278356501064557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,35197,269,1.06 [0.92-1.22],0.4231974969974903
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,40937,319,1.07 [0.95-1.19],0.2689930954085251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,35285,276,1.23 [0.98-1.56],0.0789350218273496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,41351,323,1.00 [0.70-1.43],0.9930305677766152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,41603,324,1.09 [0.95-1.26],0.2287017979327978
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,35790,277,1.05 [0.84-1.30],0.6726443405371236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,34697,267,1.07 [0.96-1.19],0.2564148965896803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",41247,323,1.02 [0.83-1.26],0.8407707980390975
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,40977,320,1.03 [0.89-1.19],0.7168697623883272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,41239,323,1.42 [1.00-2.01],0.0476653905132636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",34825,269,1.21 [1.00-1.46],0.0548415451738185
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,41045,321,1.17 [0.88-1.55],0.2861710170044201
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,35697,278,1.09 [0.75-1.60],0.6429341553306378
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,35859,278,1.33 [1.11-1.60],0.0018013529313509
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,34825,269,1.15 [0.96-1.38],0.1409367240464383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,34731,268,0.76 [0.58-1.01],0.0584082254488738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,35096,275,1.05 [0.89-1.24],0.5630182898753874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,35707,278,0.99 [0.91-1.07],0.8034275809721338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,34731,268,1.09 [0.98-1.21],0.0978807187443855
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,34731,268,1.12 [0.83-1.52],0.4490292788621127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,40937,319,1.85 [1.46-2.35],4.756011159816937e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,41612,325,0.90 [0.75-1.07],0.2279866816323836
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,34825,269,1.05 [0.67-1.64],0.832787044043872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,34602,264,1.02 [0.83-1.26],0.8461132783069043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,35697,278,1.04 [0.75-1.44],0.815075085333522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,35859,278,0.96 [0.84-1.09],0.5119985092624826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,34760,267,1.05 [0.83-1.33],0.6621836908725866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,35131,269,0.99 [0.79-1.23],0.9275212404164516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,35096,275,1.03 [0.87-1.22],0.7174670460342245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,34892,262,1.07 [0.91-1.27],0.4221199850145334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,41045,321,1.02 [0.92-1.14],0.687467008830154
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,35697,278,1.10 [0.94-1.29],0.2185434847206501
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,35790,277,1.50 [1.20-1.88],0.0004482129628029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,34731,268,0.98 [0.85-1.13],0.7848910322314656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,40502,311,1.01 [0.91-1.13],0.82121316591049
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,40301,312,1.05 [0.87-1.26],0.635113482474414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,40502,311,1.20 [1.02-1.40],0.0246175526601216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,34825,269,0.98 [0.86-1.13],0.8220232974327161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,41195,324,1.00 [0.89-1.13],0.9517082598887806
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,40580,317,0.87 [0.60-1.26],0.4686708515202571
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,35885,280,1.01 [0.87-1.19],0.8659241795094738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,41045,321,1.32 [0.80-2.17],0.2728504347532277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,34760,267,1.01 [0.90-1.14],0.8475374716409417
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,41330,322,4.91 [3.69-6.54],1.2120656913623176e-27
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,41603,324,1.25 [0.90-1.73],0.1784823061944686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,34602,264,1.01 [0.88-1.16],0.8859466472282468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,41585,325,1.30 [1.11-1.53],0.0011713199239173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,34825,269,1.00 [0.67-1.51],0.987495319142906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,41351,323,1.00 [0.84-1.19],0.980178313710734
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,41643,326,1.21 [0.92-1.58],0.1780386991899977
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,35805,276,0.79 [0.54-1.16],0.2347669309006952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,40502,311,0.98 [0.90-1.07],0.6238757342371177
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,34908,268,0.79 [0.48-1.31],0.3565191388738028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,35859,278,1.08 [0.79-1.46],0.6336914197171366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,41045,321,1.16 [1.00-1.36],0.0503661090939664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,35885,280,0.81 [0.70-0.94],0.0055689151593802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,41045,321,1.15 [0.92-1.43],0.2173030898550869
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,35197,269,1.07 [0.90-1.27],0.4376949821365423
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,41045,321,1.05 [0.93-1.18],0.4543305798966285
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,35697,278,1.01 [0.89-1.14],0.9116205856191932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,41045,321,0.97 [0.85-1.10],0.6476409879088342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,35697,278,1.17 [0.86-1.59],0.3103384460874906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,34731,268,0.97 [0.68-1.38],0.8529698994108534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,35697,278,1.38 [1.17-1.62],0.0001253940547288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,41192,323,1.75 [1.40-2.20],1.1495180539115704e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,41174,322,1.04 [0.88-1.21],0.6577642896735363
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,35790,277,0.76 [0.56-1.05],0.0961663522350532
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,40279,316,1.13 [0.93-1.37],0.2203283989104314
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,35197,269,0.92 [0.68-1.23],0.5632772766744143
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40502,311,0.87 [0.72-1.05],0.139271932550781
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,41603,324,0.98 [0.85-1.12],0.7631653178955629
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,40301,312,1.22 [0.88-1.67],0.2307346577330426
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,35096,275,1.06 [0.87-1.29],0.5945041744405328
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,41549,321,0.92 [0.72-1.16],0.4732966354950089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,34602,264,1.05 [0.91-1.21],0.493798796809363
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,40791,318,1.06 [0.82-1.36],0.6634734851912939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,35805,276,0.99 [0.77-1.27],0.950421683627248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,41742,327,1.05 [0.92-1.20],0.4483187528440152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",41247,323,1.62 [1.26-2.09],0.0002091373885051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,40496,312,1.05 [0.91-1.22],0.5020032742044156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,40502,311,1.02 [0.92-1.14],0.6693102301908237
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,40279,316,0.95 [0.85-1.07],0.4279554401854518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,35790,277,1.14 [0.98-1.31],0.0813600733277362
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,34825,269,1.09 [0.91-1.31],0.3460763664364947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,35697,278,1.28 [0.97-1.69],0.0827744843141866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,34973,274,1.12 [0.93-1.35],0.2356373889465922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,41548,321,1.12 [0.97-1.31],0.129494245627775
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,39127,303,1.88 [1.50-2.36],4.170599916395127e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40805,316,0.88 [0.69-1.13],0.3072577582420313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",41274,322,0.77 [0.58-1.03],0.0741962063593791
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,41611,321,1.15 [0.86-1.53],0.3534926372926605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,40496,312,1.37 [0.98-1.91],0.06202576564586
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40937,319,1.14 [0.95-1.37],0.1593152811895697
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,41611,321,1.42 [1.24-1.63],4.242460975309914e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,41540,327,0.98 [0.73-1.33],0.910690633559579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,34825,269,1.08 [0.88-1.32],0.4539029993873449
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,41351,323,1.02 [0.92-1.12],0.725119818368742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,40279,316,1.11 [0.86-1.45],0.4227148839860631
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,35790,277,1.42 [0.94-2.13],0.0918371797620611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",35707,278,1.02 [0.94-1.11],0.6001275682909817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,41045,321,0.99 [0.91-1.08],0.8969523753050065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,35697,278,1.13 [0.81-1.60],0.4700692568941805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,34731,268,1.06 [0.88-1.27],0.5561092463463173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,40496,312,0.98 [0.87-1.10],0.6994171473627016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,35096,275,1.02 [0.87-1.19],0.8171257042140948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,34825,269,1.43 [0.97-2.11],0.0720964127539596
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,34825,269,1.75 [1.46-2.10],1.8829416975094678e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,40301,312,1.04 [0.90-1.19],0.6079014873025033
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,40502,311,1.59 [1.35-1.88],3.485946988557691e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,34731,268,1.19 [1.01-1.39],0.036374526591126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,35707,278,0.95 [0.84-1.08],0.4434645827104114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,35790,277,1.74 [1.45-2.08],2.1402351713970318e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,34825,269,1.03 [0.76-1.40],0.8383697934361665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,35197,269,1.14 [0.96-1.35],0.132051499477164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,35697,278,1.03 [0.89-1.18],0.7306131235383356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,35707,278,1.22 [1.04-1.43],0.0129349507616369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,35697,278,0.93 [0.75-1.16],0.5222817897864545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,34908,268,0.98 [0.94-1.03],0.4862557410276972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,34602,264,0.85 [0.57-1.27],0.4247527176548789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,34760,267,0.98 [0.87-1.11],0.7917434622235818
